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ABSTRACT
SERUM-BASED BIOMARKERS AND MAGNETIC RESONANCE IMAGING FOLLOWING
MILD TRAUMATIC BRAIN INJURY IN COLLEGIATE ATHLETES POST
RETURN-TO-PLAY
By
Taylor R. Susa
Recently there has been an increase in the use of MRI (Magnetic Resonance Imaging), to
measure the effects of traumatic brain injury (TBI). Proteins such as BDNF, S100B, UCH-L1,
and Tau have been found to have altered levels in blood serum after TBI. However, there is
limited knowledge about the relationship between serum-based and MRI-based biomarkers in
concussed athletes post return-to-play. This study aimed to bridge this gap by collecting serum
samples from 42 participants across two groups. The first group (n = 21) consisted of recently
cleared to return-to-play collegiate athletes after experiencing a sports-related concussion. The
second group (n = 21) was collegiate athlete controls matched on age, sex, and sport. Structural
and functional MRI were used for analysis from a subgroup of 26 participants (13 concussed, 13
control). Blood samples were collected to assess the levels of BDNF, S100B, UCH-L1, and Tau.
To the best of our knowledge, this is the first study to analyze protein levels in association with
gray matter volume (GMV) and resting state functional connectivity (rsFC) following sportsrelated concussion. BDNF was the most effective protein at differentiating concussion from
control. Significant differential relationships were found between BDNF, S100B, UCH-L1, and
Tau with GMV and rsFC, suggesting that serum-based biomarkers may have important clinical
implications in concussion diagnosis and treatment.
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Introduction
With over 1 million emergency room visits a year and 1.7 million new cases annually in
the United States, traumatic brain injury (TBI) is widely prevalent (Wu et al., 2016). Of those
visits, 70%-90% are for mild traumatic brain injury (mTBI), more commonly referred to as a
concussion. Further, 40%-50% of those who experience a concussion are symptomatic three
months after injury (Wu et al., 2016). Physical and cognitive impairments (migraine, difficulty
balancing, lapses of attention, and memory deficits) are regularly experienced as an outcome of
concussion. Additionally, concussion is linked to elevated symptoms of depression and anxiety
(Moore et al., 2006). We assessed levels of depression, anxiety, and stress using the Depression
Anxiety Stress Scales (DASS) at the post return-to-play time point following recently concussed
collegiate athletes and age, sex, and sport matched controls.
Concussions happen most frequently in sports, falls, and vehicle accidents (Moore et al.,
2006). It is still unclear what the underlying mechanisms of concussion are long term on the
brain in regards to physical and mental health. These underlying mechanisms could be explained
with brain imaging and blood-based biomarkers.
Despite the high prevalence of concussion, there are not many studies using
neuroimaging techniques to assess the post-injury phase. MRI (magnetic resonance imaging) is a
neuroimaging technique that is used to assess a variety of clinical and research needs including
TBI (Damadian et al., 1974). Several different scans can be conducted in one single scanning
session, allowing for a thorough assessment of the brain at certain time frames including at the
onset of an injury or disease. Using MRI, to not only look at the onset, but also the period after a
concussion to measure the prolonged effects of injury in combination with their relation to
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proteins is important in neuroplasticity and could improve how post-injury recovery is evaluated
(Wu et al., 2016).
One way this can be done is by assessing functional connectivity (FC) levels which is
brain activity that is associated with regional brain activation during resting state or task-based
scanning (Ptito et al., 2007). We evaluated resting state FC (rsFC) of a task negative MRI scan in
the frontal region of the brain including the left and right dorsolateral prefrontal cortex due to its
prevalence in concussion (Czerniak et al., 2015; Eierud et al., 2014). We also assessed gray
matter volume (GMV) to evaluate structure changes in the brainstem, prefrontal cortex, and
hippocampus (Brezova et al., 2014; Churchill et al., 2017; Dean et al., 2015).
We recently assessed brain derived neurotrophic factor (BDNF), a protein that plays a
vital role in synaptic plasticity and neuronal survival with the current study’s participants (Susa
et al., 2019). Based on our findings of significantly elevated levels of BDNF in serum, a derived
component of blood, in the concussed group in comparison to controls we chose to further
evaluate other proteins in serum as potential biomarkers of concussion post return-to-play.
Previous research has indicated that S100B, ubiquitin c-terminal hydrolase L1 (UCH-L1), and
Tau in serum may compare with differences in rsFC and GMV.
The use of serum is more effective than measures of cerebral spinal fluid, saliva or urine
samples. However, when we assessed BDNF in serum, we also assessed BDNF in saliva.
Although there we did not find any significant group differences, a significant relationship was
found between serum and salivary BDNF measures in the concussed group (Susa et al., 2019).
Even though salivary samples could be evaluated in addition to the serum samples in this study
based on our findings, for the sake of serum being more robust and reliable this thesis will only
be assessing serum in S100B, UCH-L1, and Tau.
2

Several proteins exist as potential serum-based biomarkers in TBI, some in mTBI, but
none have been specified in the 1 – 45 day post-concussive phase of sports-related concussions
(Kawata et al., 2016). Recent research examining serum biomarkers in concussion have found
elevated levels of many proteins, but overall have indicated mixed results especially when trying
to assess correlations with MRI (Kulbe & Geddes, 2016; Zetterberg & Blennow, 2015). The
frontal and occipital lobes are commonly affected in concussion and the potential deficits of
these areas may correlate with the serum-based protein levels (Churchill et al., 2017; Eierud et
al., 2014).
Research suggests that S100B is related to exercise, hence it may be specific to
concussion because of the high prevalence in sports (Dang et al., 2014). Regarding Tau, previous
research has seen a significant increase in levels when concussed athletes were compared to their
own preseason measures, yet we do not know the level of Tau following a concussion when
compared to matched controls (Randall et al., 2013). UCH-L1 is one of two proteins approved by
the FDA to diagnose TBI by serum samples within 12 hours post-injury (Welch et al., 2018).
Specifically in mTBI, UCH-L1 has shown increases in non-sports related concussion in
comparison to healthy controls (Li et al., 2015). Recently, UCH-L1 has shown to have an initial
decrease when compared to baseline prior to increasing following non-sports related concussion
(Welch et al., 2018).
Based on these findings it is still unknown what the effects of these specific proteins are
when evaluated within three months post return-to-play of recently concussed collegiate athletes.
We can achieve multiple levels of analysis examining images of the brain compared to samples
of blood. Correlating protein levels in serum with MRI may be utilized as a future marker of
individual-based recovery post-concussion.
3

The present study’s first aim was to establish serum-based biomarkers in S100B, UCHL1, and Tau as an assessment of post return-to-play in athletes with a recent sports-related
concussion. The second aim was to assess changes in the structural and functional brain
networks of the concussed group compared to the control group. The third aim was to compare
MRI findings to S100B, UCH-L1, and Tau levels collected through serum samples. We
hypothesized that there would be (1) an effect of group for each protein such that higher levels of
S100B and Tau as well as lower levels of UCH-L1 would be expressed in the concussed group in
comparison to the control group, (2) differences in GMV and rsFC between groups, and lastly
(3) alterations in serum-based protein levels would be linked to differences found in GMV and
rsFC from the MRI scans between groups.
Literature Review
Traumatic Brain Injury
Prevalence. A TBI is defined by the World Health Organization (World Health
Organization, 2006) as any injury to the brain resulting from an external force that leads to a
spectrum of problems, including concussion, contusion, and/or diffuse axonal injuries.
According to the Centers for Disease Control and Prevention there were 1.88 million emergency
department visits, hospitalizations, and deaths because of TBI in the United States in 2006
(Centers for Disease Control and Prevention, 2019). By 2014, in only 8 years, that number
increased by 53% to 2.87 million TBIs (Centers for Disease Control and Prevention, 2019). In
the United States, an average of 155 people die each day from injuries including TBI, with the
leading cause of TBI-related death varying by age (Centers for Disease Control and Prevention,
2019). The leading cause of TBI-related emergency room visits in 2014 overall was falls
accounting for 48% of all injuries and 17% being struck against or by an object (Centers for
4

Disease Control and Prevention, 2019). TBI-related hospitalizations for all ages were led by 52%
falls and 20% motor vehicle crashes (Centers for Disease Control and Prevention, 2019).
Diagnosis. TBI is characterized in one of three ways; mild, moderate, or severe and most
commonly determined by the Glasgow Coma Scale (GCS) (Teasdale & Jennett, 1974). This tool
detects eye movements, verbal responses, and motor responses immediately after an injury
(Teasdale & Jennett, 1974). A GCS score can range from 3 to 15, the lower the score the more
severe the condition (Mallya et al., 2015). A value less than or equal to 8 is considered severe, a
score between 9 and 12 is moderate and anything 13 or above is mild (Jeter et al., 2013). About
80% of all TBIs are classified as mild (Bernstein, 1999; Mallya et al., 2015; Wu et al., 2016).
With such a high prevalence rate, mTBI has been coined the term “the silent epidemic” (Tellier
et al., 1999). About one quarter of those with a mTBI are hospitalized each year, 35% are treated
in the emergency room and released, 14% received some sort of outpatient treatment and 25%
received no medical care (Report to Congress on mild traumatic brain injury in the United
States: Steps to prevent a serious public health problem, 2003).
Males are twice as likely to have a head injury occur compared to females (Langlois et
al., 2006; Mallya et al., 2015; Moore et al., 2006). Other risk factors for mTBI include alcohol
consumption, substance abuse, learning disability, marital discord, area of living, or a previous
TBI (Weight, 1998). Studies have been conducted assessing the association between mental
illnesses and TBI, previous reports have been made stating that as high as 68% of psychiatric
inpatients had experienced a TBI (Burg et al., 1996). That statistic is important, because 40-50%
of people that endure a mTBI have symptoms three months after injury, thus, there could be a
potential link between psychiatric illness and concussion (Wu et al., 2016).
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All things considered, there are a large number of symptoms that individuals endure
following TBI including vision problems, anxiety, depression, and attention deficits among
others. The symptoms of mTBI and TBI have been continuously studied with different types of
neuroimaging over the years. Scientists have been trying to find what is causing these symptoms,
whether it be changes in brain volume, cortical activity, or FC patterns, etc. (Churchill et al.,
2017; Dean et al., 2015; Dettwiler et al., 2014; Ptito et al., 2007). These studies are assessing TBI
at all levels from mild to severe. An emerging facet of TBI research is a recent focus on sportsrelated concussion due to an increase in the number of concussions being experienced and the
safety in sports surrounding head injury.
History of Sports-related Concussion. Concussion is a word that was coined back in the
1660s for a certain type of head injury. The word evolved from the earliest work on head injuries
over 2,000 years ago (McCrory & Berkovic, 2001). The meaning of concussion is largely
clinical with many changes that have taken place in the definition throughout the past 150 years.
Back in the 19th century after the Civil War (1861-1865), American football saw a rise in
popularity (Stone et al., 2014). Unfortunately, at this time there was no protective equipment for
those who participated. Seasons were characterized by the number of deaths and serious injuries
with the majority of these happening to the head (Stone et al., 2014). Eventually, in 1935,
helmets were made mandatory at the high school level and then in 1939 at the college level, skull
protection was finally making an appearance (Mueller & Blyth, 1982). In the 1960s the Congress
of Neurological Surgeons defined concussion as follows, “a clinical syndrome characterized by
immediate and transient impairment of neural function, such as alteration of consciousness,
disturbance of vision, equilibrium, etc., due to mechanical forces” (Gurdjian & Voris, 1966).
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After the largest number of head and neck injuries was reported in the 1960s for football
players there were rule changes implemented at the college level in 1978 and the high school
level at 1980 (Mueller & Blyth, 1982). The 1978 rule prohibited blocking or tackling to have any
contact with the head and face (Stone et al., 2014). Since this rise in the number of injuries
reported, neurologists in the past 50 years have become more involved in sports-related
concussions as the most popular sports tend to be the ones with the most head injuries (Dunn et
al., 2006).
In the early 1990’s, Dr. James Kelly, a neurologist, devised a sports concussion
classification system (Kelly et al., 1991). In 1997 this was modified, and the emergence of
return-to-play recommendations were made. At this point medical professionals were also
making a reference to second impact syndrome. When a concussion was first recognized the
player was then removed from the game (Kelly & Rosenberg, 1997). If the player was
completely asymptomatic at rest within 15 minutes, the physician and athletic trainers considered
the athlete’s return-to-play that very day. Notion of post-concussion syndrome began being taken
more seriously around this time stating that it consisted of headache with exertion, dizziness,
fatigue, irritability, impaired memory and concentration, and could last several weeks or longer
(Guthkelch, 1980; Murphey & Simmons, 1959).
In 2001, the first international symposia on concussion in sport was held in Vienna,
Austria. The original aims of this meeting were to provide information about possible
improvements for the health and safety of athletes that may suffer a concussion in the following
sports; American football, rugby, soccer, ice hockey, etc. (McCrory et al., 2005). A definition for
concussion rose from the meeting; “sports concussion is defined as a complex
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pathophysiological process affecting the brain, induced by traumatic biomechanical forces”
(McCrory et al., 2005, p. 196).
At the fourth meeting in 2012, it can be concluded that although mild traumatic brain
injury and concussion are terms often used interchangeably in the sporting context, a concussion
is a subset of TBI (McCrory et al., 2013). It was at this meeting where it was also stated that 8090% of concussions resolve in a 7 to 10 day period, although this may not be true of everyone
(McCrory et al., 2013). Persistent symptoms lasting longer than 10 days are typically reported in
10-15% of concussions (McCrory et al., 2013). At this concussion symposia it was determined
that there should be no clearing of athletes to return-to-play on the same day of injury.
In 2016 at the fifth and most recent Concussion in Sports Group meeting in Berlin,
Germany, there was a consensus to replace the term “Post-Concussion Syndrome” with
“Persistent Concussion Symptoms” which was described as “a constellation of non-specific posttraumatic symptoms that may be linked to co-existing and/or confounding factors” (McCrory et
al., 2017, p. 5). It was decided that the term persistent symptoms should be used when symptoms
are experienced more than 10-14 days following injury for an adult and more than four weeks
following injury for a child (McCrory et al., 2017).
Concussion at the Cellular/Molecular Level. Any neurologic dysfunction resulting
from a biochemical force is defined as a concussion (Giza & Difiori, 2011). A loss of
consciousness may happen, but is not a concrete symptom to qualify as a concussion diagnosis
(Giza & Difiori, 2011). The neuronal dysfunction that tends to occur with concussion can be
changes in neurotransmission, ionic shifts, altered metabolism, or impaired connectivity (Giza &
Hovda, 2001).
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Concussion is not a macro structural brain injury, but rather a functional disturbance
(Leddy et al., 2017). After a biomechanical injury to the brain there is an immediate disruption in
the neuronal membranes, axonal stretching, and opening of the voltage gated potassium (K+)
channels (Giza & Difiori, 2011). This then leads to an increase in K+ extracellularly (Katayama
et al., 1990). Normally, the excessive K+ found extracellularly is taken up by glial cells (Paulson
& Newman, 1987). Usually the brain by this mechanism can overcome small disturbances, but in
the case of an event such as brain trauma, this method of compensation is not enough
(D'Ambrosio et al., 1999). The massive excitation that has occurred is followed by a wave of
neuronal suppression, which can also be referred to as “spreading depression” (Giza & Hovda,
2001). An important distinction between classic spreading depression and post concussive K+
fluxes is that after trauma has been endured, diffuse areas of the brain are effected all at once
(Giza & Hovda, 2001).
Energy-requiring membrane pumps are then activated, triggering an increase in the use of
glucose to restore the ionic homeostasis of the cells (Richards et al., 1987). This acceleration of
glycolysis increases lactate production, this action is seen in both stroke and concussion injuries
of animal models (Richards et al., 1987). The oxidative metabolism in the brain is also altered by
trauma and can lead to reduced adenosine triphosphate production which will provide another
stimulus to increase glycolysis, again increasing lactate production (Giza & Hovda, 2001).
Elevated levels of lactate can induce acidosis, altered blood brain barrier permeability, cerebral
edema, and membrane damage by neuronal dysfunction (Gardiner et al., 1982). In TBI
specifically, the increased levels of lactate can leave neurons vulnerable to a secondary injury
(Becker et al., 1988).
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Within hours of injury there is an accumulation of calcium as well as reduced
intracellular levels of magnesium that can persist for up to four days after injury (Vink et al.,
1988). Positron emission topography (PET) scans have shown decreases in the cerebral glucose
metabolism of the brain that can last for 2-4 weeks following injury (Bergsneider et al., 2000).
This type of glucose metabolism was seen in patients on both ends of the GCS spectrum
(Bergsneider et al., 2000). This kind of neurotransmitter alteration has also been found in the
cholinergic, adrenergic, and glutamatergic systems (Miller et al., 1990). These changes may be
what causes deficits in memory and cognition after a concussion.
All the changes that can happen when a brain undergoes a concussion are difficult to
examine in human models, thereby much of the work that has been done uses animal models.
However, PET scans have demonstrated the depressed glucose metabolism in patients, but
unfortunately this was seen in all aspects of the GCS range (Giza & Hovda, 2001). The
physiology of concussion needs to be translated better over to humans for a greater
understanding of the injury and so it can have clinical applicability to help the many who suffer a
concussion every year.
Time Course of Post-concussive Symptoms. As mentioned, lingering effects of
concussion can remain for more than 10 days post-injury and sometimes even up to months later,
the symptoms experienced are known as post-concussive symptoms, classified by the
International Classification of Diseases, 10th edition (ICD-10) (World Health Organization,
1992). Some of the symptoms include headache, dizziness, fatigue, anxiety, and depression, most
people recover from these symptoms 1-3 months following injury (Belanger et al., 2005), but
24%-40% of people with concussion have reported experiencing these three months post-injury,
with 10%-20% of people reporting these symptoms more than a year later (Bernstein, 1999;
10

Iverson et al., 2007; Wu et al., 2016). Post-concussive symptoms are not limited to only
concussion, but can also be experienced after injury for any severity of TBI. Except, studying the
symptomology is rather difficult because the nature of these symptoms goes beyond the specifics
of TBI (Iverson et al., 2007) and long term follow-up is not completed or lost.
However, in a study conducted by Sigurdardottir and colleagues (2009) people diagnosed
with mTBI reported post-concussive symptoms significantly more than moderate or severe at
three months post injury. At one year following injury no significant differences were found in
the presence of symptoms between groups (Sigurdardottir et al., 2009). It would have been
beneficial for these researchers to include the MRI results that were collected in conjunction with
the questionnaires at one-year post-injury. Inclusion of an MRI scan at three months post-injury
when the discovery of mTBI participants reporting more symptoms than the moderate or severe
participants would give a greater insight as to why the mTBI group might be experiencing more
symptoms. A study conducted by Meares and colleagues (2008 & 2011) observed whether
having a mTBI could predict if post-concussive symptoms would be experienced at three months
after injury, but was unsuccessful (Meares et al., 2008; Meares et al., 2011). Researchers did not
find that mTBI predicted post-concussion syndrome in the acute phase following injury. It is
important to note that the control group used in this study was a sample of non-brain injured
trauma controls. Therefore, measuring symptomology such as pain, anxiety, stress, and
depression, all of which have been found to be commonly experienced after a concussion can
also be experienced following any type of trauma. Future studies should use a non-injured
control group, but also consider pre-existing comorbidities i.e. chronic pain, depression, or
anxiety disorders.
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One of the ways that concussion symptoms are assessed in sports is by the Immediate
Post-Concussion Assessment and Cognitive Testing (ImPACT). The ImPACT test created by
Lovell and colleagues (ImPACT, 2003), consists of three main sections; demographic data,
neuropsychological tests, and the Post-Concussion Symptom Scale (PCSS) (Schatz et al., 2006).
The 2.0 version of the ImPACT test has six neuropsychological tests assessing different areas of
cognition including reaction time, processing speed, attention, and memory (Schatz et al., 2006).
When combined these sections provide data used to assist in the assessment and recovery of
concussions based on four key composite scores: verbal memory, visual memory, visuomotor
speed, and reaction time. In this thesis we focused solely on the PCSS component of ImPACT.
Ideally, the ImPACT test would be completed at the start of every academic year or
athletic season to be utilized as baseline. Baseline testing is important in sports, because when an
athlete has a concussion the data collected during baseline is typically used to determine the
individual’s “normal” (non-injured levels). In doing so this then provides a more individualized
treatment plan/recovery time. However, whether baseline ImPACT or the successive ImPACT
tests following post-concussion, research has found that some athletes “sandbag” their scores in
an effort to return to play sooner (Higgins et al., 2017). The term sandbag in this context refers to
athletes purposely scoring low on their baseline testing so in the event of a concussion they will
likely be able to return-to-play sooner. ImPACT’s Impulse Control Composite Score detects
some of these issues along with in module detection systems limiting the issue of “sandbagging”,
however it is important to educate athletes taking the tests on why they should do their best as
well as individuals reading the results to red flag these cases and repeat testing. Despite this
issue, ImPACT has been utilized by institutions at all levels ranging from high school to

12

professional level sports in order to better assess concussion on a case by case symptom basis as
the best current test available.
Assessing symptoms during concussion as well as post-concussion is subjective, as they
are self-reported without consistent scoring mechanisms (i.e. a dizziness score of 5 means the
individual experiences dizziness in most daily activities and it limits several activities a day),
making this a hard concept to study or measure reliability. It does not help that as an incredibly
individual species, humans’ bodies’ reactions to the same kind of injury varies. Although, there
has been a recent interest in correlating some of these behavioral changes with neuroimaging
techniques like MRI especially in sports-related concussion.
Neuroimaging of Concussion. MRI is a neuroimaging technique that stemmed from
nuclear magnetic resonance in the 1970s (Damadian et al., 1976), using radio waves, strong
magnetic fields and gradients to create anatomical images of the brain (Damadian et al., 1974).
MRI can detect diseased tissue from normal tissue through different magnetic strengths
measured in teslas (T) ranging from 1.5T to 9T. The standard strength of an MRI scanner used
for clinical purposes is 1.5T.
In the 21st century neuroimaging such as MRI has been more readily available for
describing the acute and chronic effects following TBI. MRI specifically, has created an increase
in diagnostic accuracy in identifying TBI due to the high signal and contrast to noise ratio, high
spatial resolution, and the different tissue contrasts that can be generated (Suskauer & Huisman,
2009). For head injuries, MRI has been demonstrated to have a higher sensitivity in diffuse
axonal injury in comparison to computed tomography (CT) scans (Lee et al., 2008).

13

T1 and T2 weighted sequences are frequently used in MRI studies for their spin-echo or
fast spin-echo sequences (Suskauer & Huisman, 2009). Shorter repetition time of the
radiofrequency pulse sequences produces T1 images where gray matter is darker than white
matter. Longer repetition times of those radiofrequency pulse sequences produce T2 weighted
images, appear brighter, with focus on the cerebral spinal fluid. Fluid attenuated inversion
recovery is another type of sequencing that is also studied for structural measures. Not only is
MRI capable of obtaining a spatial distribution of the entire body, but it also allows for various
types of scans to be conducted including diffusion weighted imaging (DWI), diffusion tensor
imaging, (DTI) and functional magnetic resonance imaging (fMRI).
Advanced MRI methods can be used to establish subtle post-injury abnormalities in brain
metabolism, cerebral microstructure, and function (Churchill et al., 2017). In the last decade
these specific types of potential brain abnormalities have been assessed following brain injury,
including GMV, cerebral blood flow, rsFC, and cortical thickness (Brezova et al., 2014;
Churchill et al., 2017; Czerniak et al., 2015; Dean et al., 2015; Meier et al., 2016; Rigon et al.,
2017; Wu et al., 2016).
For the sake of this thesis, we used a T1 weighted scan to establish the potential
alterations between groups in GMV. The composition of gray matter is in large glial cells,
capillaries, and neuronal cell bodies in which GMV is the density volume of gray matter in
certain areas of the brain or the brain as a whole (Eierud et al., 2014). In previous concussion
literature, various findings have been made with GMV using T1 weighted scans (Brezova et al.,
2014; Churchill et al., 2017; da Costa et al., 2016; Dean et al., 2015; Killgore et al., 2016; Singh
& Killgore, 2016; Sussman et al., 2017; Terpstra et al., 2017).
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Dean et al. (2015) discovered reduced gray matter in the precuneus, medial temporal and
inferior parietal lobe in a small sample of people following concussion compared to non-head
injured controls. An association was found between post-concussion symptom scores and lower
GMV in the voxel-based morphometry analysis conducted by Dean et al., (2015). Sussman and
colleagues (2017) also found reduced GMV following a single concussion in a male only sample
of recently concussed athletes versus controls (Sussman et al., 2017). However, the researchers
did not specify location of their findings. Despite not indicating specific locations of significance
these researchers interestingly mentioned that they did not find significance in subcortical
structures or the cerebellum (Sussman et al., 2017).
Da Costa et al. (2016) assessed mTBI in an older population in which they also
discovered reduced GMV between experimental and control groups following injury (da Costa et
al., 2016). Their experimental group consisted of 25 patients following a mTBI and 19 of those
patients participated in a second check in. The researchers defined mTBI as manifestation of one
of the following: alteration in mental state with a GCS score <13 after 30 minutes; amnesia time
less than 24 hours; loss of consciousness less than 30 minutes; and focal neurological deficits
based on the American Academy of Neurology criteria (da Costa et al., 2016, p. 2) The first time
point was on average 64 days post-injury and the second time point was on average around 180
days following injury (da Costa et al., 2016). Roughly two months and six months had lapsed
since injury. Researchers noted a positive correlation between cerebrovascular activity and sport
concussion assessment tool (SCAT2) scores with GMV.
A study conducted in 2017 discovered that athletes with a prior history of concussion had
lower volumes in their frontal cortex and cerebellum, however, they found higher volumes in the
hippocampus and caudate (Churchill et al., 2017). Like Dean et al. (2015), Churchill and
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colleagues (2017) also saw reduction of GMV in the middle temporal lobes. Qualifications for
inclusion to the Churchill et al. (2017) study were number of previous concussions, time in
months since last concussion, and recovery time for the most recent concussion. All of these
participants were active athletes and none were assessed immediately following injury. Half of
the participants were athletes with no documented history of previous concussion used as the
control group. Although there were significant differences found between the athletes with a
prior history of concussion and those without, the average time since injury was around two
years and recovery time was about two and a half weeks. It is important to know these numbers
to understand what these differences mean on a larger scale – the length of time showcases that
even after a couple years there are still differences between injured and healthy brains.
Contrary to Churchill et al. (2017), two studies found decreases in hippocampus volume
(Brezova et al., 2014; Terpstra et al., 2017). Brezova and colleagues (2014), evaluated GMV
during the first year following moderate or severe TBI, not concussion. Despite the higher
severity of TBI studied by Brezova et al. (2014), the differences found in the hippocampus were
not significant until the 12-month time point following injury and only saw gradual changes up
until that point. The patients who suffered post-traumatic amnesia longer than two weeks were
more likely to have smaller hippocampi. They also noted a significant decrease in GMV of the
brainstem between the early and three-month scans that they conducted. The more severe the
injury the greater the difference in brainstem volume. The study conducted by Terpstra et al.
(2017) found decreased hippocampal volume associated with higher symptoms of anxiety, based
on the Beck Anxiety Inventory, following moderate to severe TBI. Researchers specifically
assessed the right anterior hippocampus and discovered that anxiety symptomology could predict
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hippocampal atrophy at five- and twelve-months following injury, but not based on whole brain
volume (Terpstra et al., 2017).
Unlike previous TBI research which has found decreased GMV (Brezova et al., 2014; da
Costa et al., 2016; Dean et al., 2015; Sussman et al., 2017; Terpstra et al., 2017), Killgore and
colleagues (2016) discovered increased GMV correlated with time since injury (Killgore et al.,
2016; Singh & Killgore, 2016). A total of 26 patients were included from one of five time points
following mTBI: two weeks, one month, three months, six months, and one year (Killgore et al.,
2016). These participants were divided into two equal experimental groups based on their time
since injury. The first group (n=13) consisted of individuals who had experienced a mTBI in the
previous 0 - 99 days and were classified as the post-acute group for analysis (Killgore et al.,
2016). The second group (n = 13) consisted of individuals who had experienced a mTBI in the
previous 100 - 367 days and were classified as the chronic group for analysis (Killgore et al.,
2016). The control group (n = 12) was healthy individuals without a history of concussion or loss
of consciousness. GMV significantly differed in the right fusiform gyrus and ventromedial
prefrontal cortex/gyrus rectus between groups where chronic mTBI had the highest increase in
GMV (Killgore et al., 2016; Singh & Killgore, 2016). This increase in GMV was only significant
in chronic mTBI compared to post-acute mTBI and healthy controls in the ventromedial
prefrontal cortex/gyrus rectus. However, in the fusiform gyrus, the healthy controls were found
to have significantly higher GMV compared to post-acute mTBI and chronic mTBI displayed
significantly higher GMV compared to the healthy controls (Killgore et al., 2016; Singh &
Killgore, 2016).
Even with the amount of previous research conducted using T1-weighted scans to assess
GMV following TBI and concussion there is uncertainty behind these results. The trouble with
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these previous findings is the inconsistencies in when TBI is assessed following injury as not all
time points have been adequately addressed. Our findings are an important addition to the field,
especially with our experimental group within 1-45 days since return-to-play and an age, sex,
and sport matched control group.
This thesis also utilized an fMRI scan to determine any changes in FC to the brainstem,
prefrontal cortex, and the hippocampus. fMRI takes MRI one step further, enabling the location
of function in the brain. The use of fMRI could provide insights into the function and
pathophysiological aspects of injury (Ptito et al., 2007). fMRI scans can be both resting state
(non-task based) and task based. In our study we only assessed rsFC, the measure of regional
connectivity when the brain is at rest, to better understand the effect of concussion on the brain
following post return-to-play in recently concussed collegiate athletes. Numerous studies have
previously evaluated rsFC following TBI and concussion (Bharath et al., 2015; Czerniak et al.,
2015; Eierud et al., 2014; McCrea et al., 2017; Meier et al., 2017; Militana et al., 2016; Shin et
al., 2017; Slobounov et al., 2011; Zhu et al., 2015).
rsFC differences have been previously found between concussed and control athletes in
the anterior cingulate cortex, left dorsolateral prefrontal cortex and the right dorsolateral
prefrontal cortex seed regions (Czerniak et al., 2015). Czerniak et al. (2015) was a very small
sample size of collegiate athletes, but gave an idea as to how concussed brains show a stronger
connectivity when compared to age-matched controls. In a review by Shin et al. (2017) they
discovered that fMRI gives an insight into specific measures by which concussion leads to
alterations in brain function (Shin et al., 2017). This was brought on by the dysregulation in
connectivity seen at both resting state and active state (task-based) measures (Shin et al., 2017).
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Meier and colleagues (2017), conducted a study with recently concussed athletes at one
day, an acute time point, as well as one week and one-month, subacute time points following
injury to evaluate patterns of FC. Several areas had an increase at the subacute time point relative
to the acute including the supplementary motor area (SMA), postcentral gyrus, paracentral
lobule, lingual and fusiform gyri, the middle and superior temporal gyri (Meier et al., 2017). The
middle and superior temporal gyri along with the superior medial frontal gyrus displayed a
significant effect of time with FC in these levels decreased based on time since injury (Meier et
al., 2017). The participants for this study were recruited from all sports from the department of
athletics at a NCAA Division I school.
In 2015, Bharath and colleagues also evaluated rsFC longitudinally following mTBI. A
total of 25 participants suffered from a non-sports-related mTBI and 21 participants were healthy
controls (Bharath et al., 2015). The following time points were assessed post-injury: 36 hours,
three months, and six months with region of interest (ROI) based connectivity. In whole brain
group level analyses researchers discovered 33 ROI pairs between mTBI and healthy controls
(Bharath et al., 2015). For the mTBI group during the recovery period 18 ROI pairs were
discovered with most either from the three months to six-month time points or the 36 hours to
six-month time points (Bharath et al., 2015). The group level comparisons between the three
recovery time points and healthy controls revealed 15 ROIs. Most of the changes that occurred in
the first three months were decreased connectivity and the changes that took place between three
and six months were increased connectivity (Bharath et al., 2015). All of the significant
differences in rsFC in this study took place predominantly in the frontal and parietal lobes
including areas such as: the precuneus, superior parietal lobule, postcentral gyrus, and the
bilateral frontal lobes (Bharath et al., 2015). The findings of Bharath et al.’s (2015) study give
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insight into the effects of mTBI in general, but do not specifically address the ramification
sports-related concussion has on the brain.
A sports-related concussion study conducted by Slobounov et al. (2011) assessed rsFC at
on average ten days post-injury with 17 recently concussed collegiate athletes and 17 athlete
controls without a history of concussion. The statistical parametric mapping 8 package (SPM8)
and CONN, a functional connectivity toolbox were used to analyze the data with four ROI-based
regions; the right dorsolateral prefrontal cortex, bilateral precuneus, bilateral primary visual
cortex, and the bilateral hippocampus (Slobounov et al., 2011). Significant reductions were
found in the primary visual cortex, hippocampus, and dorsolateral prefrontal cortex seeds, where
the concussed group had weaker connectivity then the controls. However, the difference between
groups in the precuneus did not reach significance (Slobounov et al., 2011).
Similarly, to Slobounov et al. (2011) on a smaller scale Militana and colleagues (2016)
further evaluated rsFC within one week of a sports-related concussion. ROI-based analysis was
also conducted to determine group differences, however, there were 18 different ROIs selected
based on the default mode network (DMN), dorsal attention network (DAN), and the
frontoparietal control network (FPC) (Militana et al., 2016). Increased connectivity was
discovered in three regions of the DMN, the bilateral hippocampus, precuneus, and dorsolateral
prefrontal cortex where the concussed group exhibited stronger connectivity compared to
controls (Militana et al., 2016). As mentioned, there was a small sample size of only seven
recently concussed athletes and 11 healthy controls which needs to be taken into consideration
when evaluating these results.
Correspondingly, Zhu et al. (2015) also assessed rsFC in a small subset of concussed
athletes (n = 8) compared to controls (n = 11) in the DMN. Researchers selected the following
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eight nodes for analyses: bilateral posterior cingulate cortex, bilateral anterior cingulate
cortex/medical frontal cortex, bilateral superior frontal gyri, and bilateral inferior parietal
lobules/angular gyri (Zhu et al., 2015). All athletes displayed symptoms immediately post-injury
and were assessed at one day, seven days, and 30 days following injury. There was a significant
time and group interaction discovered in the overall DMN, bilateral hippocampus, and right
posterior cingulate cortex where DMN exhibited higher connectivity on day one compared to
day seven (Zhu et al., 2015). When compared to the controls, reduced FC in the DMN was
significant on day seven in the bilateral hippocampus, bilateral superior frontal gyri, and right
inferior parietal lobule/angular gyrus. Furthermore, no significant differences were found
between the concussed athletes and controls in respect to day one and day 30 following injury
(Zhu et al., 2015). The ImPACT results from this study need to be considered when addressing
these FC results as on average athletes in this sample appeared to be recovered or performed
better than on their baseline within about six days after obtaining a sports-related concussion.
This is important as some of the athletes most likely still displayed symptoms at the day seven
time point where as others may not have and was not accounted for in the FC analyses.
A recent review on advanced neuroimaging in sports-related concussion included eight
studies that assessed rsFC and noted findings seemed to vary, however, these differences most
likely existed based on the variations of methodology used (McCrea et al., 2017). McCrea and
colleagues (2017) found that the DMN was most extensively studied, but has resulted in
differing findings as some previous studies have found an increase in connectivity and others
have found connectivity to decrease in the DMN following sports-related concussion. There have
also been findings in regards to alterations in FC in areas pertaining to executive functions,

21

visual and motor networks, however, these too vary based on the methodology used, i.e. timeline
of data collection, whether athletes are experiencing symptoms or they are asymptomatic, etc.
Additionally, Eierud et al. (2014) also addressed the current state of neuroimaging
following mild traumatic brain injury in their combined review and meta-analysis. Unlike
McCrea et al. (2017), this review also included studies utilizing structural MRI measures in
which they discovered only two studies evaluated gray matter abnormalities, one used a T1
weighted scan and the other addressed these changes with a CT scan (Eierud et al., 2014). In
response to publications utilizing fMRI, an anterior-to-posterior approach was suggested based
on connectivity analysis findings of several studies. This approach was developed based on
consistent discovery of reduced connectivity in the anterior portion of the brain and increased
connectivity commonly located in the posterior regions. These regions of reduced activity were
located in the inferior parietal lobes, insula, and cerebellum, where the mTBI group displayed
less activity compared to controls, whereas controls had increased activity relative to mTBI
participants in regions of the frontal lobe and angular gyrus (Eierud et al., 2014).
A majority of previous rsFC literature pertains to regions of the DMN, however, there are
various findings in relation to the effects of concussion on the areas involved in this network.
Our present study is imperative in generating a better understanding in rsFC of asymptomatic
athletes following sports-related concussion at the post return-to-play timepoint as recent
findings suggest there to be differences relative to controls. Further, we used ROI to voxel-based
analysis to address FC in the bilateral hippocampus, brainstem, bilateral salience right prefrontal
cortex (RPFC), and the bilateral frontoparietal left prefrontal cortex (LPFC) seeds.
The use of MRI in TBI research has granted a further understanding into the aftermath of
injury on the brain and has led to various types of analysis including assessment of structural and
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functional changes. The predominance of MRI compared to other neuroimaging methodology
utilized in concussion research depicts the need to integrate with fluid biomarkers. As the
inclusion of serum-based biomarkers in addition to current neuroimaging is vital in
comprehending the effect of brain injury at a biological level. Specifically, the use of GMV and
rsFC in conjunction with serum-based biomarkers is an area of concussion research that has not
been explored in great detail. Although this is fairly new territory there is a need to incorporate
protein levels with MRI in order to notably validate the use of blood or saliva samples to
diagnose concussion.
Serum-Based Biomarkers
Background. Despite the high prevalence of sports-related concussion there are not
many studies using protein-based biomarkers to assess the timeline of concussion, especially in
regards to MRI-based biomarkers. “Biomarker” is a term broadly used to define a subgroup of
medical signs; “objective indications of medical state observed from outside the patient – which
can be measured accurately and reproducibly” (Strimbu & Tavel, 2010). Protein-based
biomarkers are measures of protein levels in the body that can tell us about a certain type of
disease and are typically assessed using serum, plasma, saliva, and cerebral spinal fluid. The use
of serum, a derived component of blood, is more effective and easier to obtain than measures of
cerebral spinal fluid samples. Recently this approach has seen an increase in use to study
diseases and injuries like TBI. Using protein levels, to understand the brain physiologically in
both healthy and injured brains is important in understanding the trajectory of injury.
Biomarkers for TBI/Concussion. A number of proteins exist as potential biomarkers of
serum in TBI, some in mild TBI, but none have been specified in the 1-45 day post-concussive
phase of sports-related concussions (Kawata et al., 2016). Proteins associated with the recovery
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of brain function have been assessed before in TBI including; Alpha-synuclein, Neuron-specific
enolase (NSE), Glial fibrillary acidic protein (GFAP) all of which have been reported to
experience sudden increases after TBI (Kawata et al., 2016; Zetterberg & Blennow, 2015).
Recently this approach has seen an increase in use to study diseases and injuries like TBI. Using
protein levels, to understand the brain at a biological level in both healthy and injured brains is
important, as is studying the time line of injury to gain a better picture. If this were done, postconcussion treatment could be greatly improved.
We recently assessed BDNF, a protein that plays a vital role in synaptic plasticity and
neuronal survival with concussed and age, sex, and sport matched controls at the post return-toplay time point (Susa et al., 2019). Based on our findings of significantly elevated levels of
serum-based BDNF in the concussed group in comparison to controls we chose to further
evaluate other proteins in serum as potential biomarkers of concussion post return-to-play. This
project is going to focus on four specific protein-based biomarkers to gain a better overall
understanding on what their potential roles may be at an asymptomatic timepoint in conjunction
with structural and functional MRI scans following sports-related concussion. The four proteins
will be BDNF, Tau, S100B, and UCH-L1.
Research suggests that S100B may be specific to concussion, particularly sports-related
due to the high prevalence because it is heavily related to exercise (Dang et al., 2014). A
previous study conducted by Randall and colleagues (2013) found a significant increase in Tau
levels when concussed athletes were compared to their own preseason measures, yet it is
unknown what effect concussion may have on Tau after injury when compared to matched
controls (Randall et al., 2013). Specifically in mTBI, UCH-L1 was found to increase following a
non-sports related concussion when in comparison to healthy controls, but it is unknown what
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the effects are following a sports-related concussion (Li et al., 2015). Based on these findings
there is still a lot of unknown territory to be explored to discover what the effects of these
specific proteins are when evaluated post return-to-play in a collegiate athlete recovering from a
head injury. Tau and S100B have been frequently implicated in concussion, but UCH-L1, is a
relatively newer protein being used as a possible biomarker for concussion even though it has
been studied for severe TBI (Kawata et al., 2016; Kulbe & Geddes, 2016; Strathmann et al.,
2014; Zetterberg & Blennow, 2015). It is unclear how UCH-L1 compares to BDNF, Tau or
S100B in testing for concussive effects post return-to-play or the possible implications these
proteins may have in relation to MRI measures.
Brain-derived Neurotrophic Factor. BDNF is a type of protein that is essential for the
development and functioning of the central and peripheral nervous systems (Mandel, Ozdener, &
Utermohlen, 2009). It is the most abundant neurotrophin in the central nervous system, however,
BDNF has also been found in plasma and blood platelets (Rosenfeld et al., 1995; Yamamoto &
Gurney, 1990). Furthermore, BDNF is composed of two forms, proBDNF and mature BDNF
(mBDNF). The precursor molecule of BDNF that is first synthesized in the cells is known as
proBDNF. ProBDNF plays an important role in dimerization and proper folding, it is involved in
the targeting of mature BDNF. Majority of mBDNF is released by neurons in an activitydependent manner or through constitutive secretion and binds to the tropomyosin-related kinase
receptor (Chen et al., 2013; Massa et al., 2010; Mowla et al., 2001). Mature BDNF also binds to
neurotrophin receptor p75 performing via interactions between these trans-membrane receptors
(Chen et al., 2013; Massa et al., 2010). These actions can happen at once or separately,
ultimately leading to either neuronal survival or death. Although proBDNF is necessary for
mBDNF, these two forms can elicit their own distinct effects (Mandel et al., 2009). Cell
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development and differentiation are promoted by mBNDF, whereas proBDNF brings about
cellular apoptosis (Mandel et al., 2009).
BDNF communication following head injury appears to have a neuroprotective effect.
Despite its size, BDNF can cross the blood brain barrier in both directions, from the periphery to
the brain and the brain to the periphery (Ferris et al., 2007). This is possible via a high-capacity
saturable transporter system (Pan et al., 1998). This means increased levels of BDNF can reflect
either the brain levels or the periphery, but is hard to tell unless collecting cerebral spinal fluid in
conjunction with serum or plasma samples. It is thought that high levels of BDNF exhibit active
recovery following injury.
BDNF post-injury. The initial TBI of any severity can also be known as the primary
injury. The effects that happen in a result of that primary injury are known as secondary injury. It
seems that BDNF plays a major role in secondary injury following TBI, through changes in
BDNF-induced gene expression of traumatized brain tissue, providing neuroprotection and
restoration of connectivity (Kaplan et al., 2010). However, the majority of BDNF biomarker
research conducted in regards to any form of TBI has been utilizing animal models (Kaplan et
al., 2010; Massa et al., 2010). Due to the nature of these therapeutic studies, primarily those
using spinal cord, it is difficult to translate and/or compare with human findings, therefore,
leading to a lack of literature on sports-related concussion specifically. Animal studies are
difficult to translate to humans, because they are not able to accurately translate pre-existing
variables in humans such as the amount of time someone has played a sport, length and use of
medication, or family history, etc.
In a small study (n = 14) of children with a severe TBI, plasma and cerebral spinal fluid
were collected at 2 hours and 24 hours post-injury in comparison to controls (Chiaretti et al.,
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2003). Although none of these TBIs were caused by sports, among the proteins they assessed,
BDNF was significantly higher between the two time points following injury in both plasma and
cerebral spinal fluid. Chiaretti et al (2003) findings suggest that BDNF may be a good indicator
of injury severity.
As mentioned previously, we assessed BDNF in both serum and saliva in a sample of 30
collegiate athletes (table 1), half of which were recently cleared to return-to-play after sustaining
a concussion and the other half were age, sex, and sport-matched controls (Susa et al., 2019).
One of the additional measures we collected was behavioral data evaluating levels of depression,
anxiety, stress using the DASS questionnaire. All the subscales and total scores were
significantly elevated in the concussion group (table 1). We found significantly elevated levels of
BDNF in serum between groups, see figure 1a (Susa et al., 2019). Furthermore, between groups
saliva BDNF levels were not significantly different, but did exhibit a similar trend, see figure 1b
(Susa et al., 2019). A correlation between serum and salivary-based BDNF levels did not exist,
see figure 1c (Susa et al., 2019). Three outliers (2 concussion & 1 control) were excluded from
all analyses involving saliva after observations of box and whisker plots indicated that were >
three SDs above the respective group M.
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Figure 1. Serum and salivary BDNF. (a) Serum levels were significantly higher in the
concussion group relative to the controls. (b) Salivary BDNF was also higher in the concussion
group compared to the control group, but did not yield significance. (c) Serum and salivary
BDNF levels were not correlated between groups. Reprinted from “Elevated levels of serum, but
not salivary, brain-derived neurotrophic factor following mild traumatic brain injury in collegiate
athletes post return-to-play,” by TS. Susa, 2019, Journal of Concussion, 3, 4. Copyright [2020]
by Dr. Joshua M. Carlson. Reprinted with permission.

Effects of exercise on BDNF. A 2011 study conducted by Bamac and colleagues (2011)
assessed the effects of a repetitive heading exercise in professional male soccer players. They
found significantly elevated levels of BDNF following the exercise compared to baseline
measures (Bamac et al., 2011). These findings may be contradictory depending on what defines
exercise as Bamac et al (2011) described the use of heading only to mimic sub-concussive blows
to the head. Another study found salivary BDNF levels increased in non-athletes in response to
an exercise program, but serum was not assessed nor were the participants concussed or recently
concussed (McGeown et al., 2016).
It is thought that exercise might be a useful treatment for concussion due to the known
increased effects with BDNF (Kaplan et al., 2010). However, this potential treatment approach is
based on an animal study comparing rats with a TBI who had access to a running wheel and
those who did not (Griesbach et al., 2002). The animals who were in the running wheel group
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showed increase cognition and levels of BDNF following exercise compared to those who
recovered without access to a running wheel.
S100B. S100B is a protein primarily expressed in astrocytes and belongs to a multi-genic
family of calcium binding proteins, it is mainly found in astroglia and Schwann cell cytosol
(Donato, 2003; Korfias et al., 2007). S100B partially gets its name from its solubility in a 100%
saturated solution with ammonium sulphate (Michetti et al., 2012). The other portion comes from
the term S100, used to describe a large gene family of mostly calcium-binding proteins (Michetti
et al., 2012). Notably, S100B, is the beta-beta homodimer of the S100 protein family. The exact
biological role of S100B is heavily debated. When secreted, it is thought to act on nearby cells
and/or the signaling cell at physiological concentrations. However, at higher levels it is thought
to elicit toxic effects (Michetti et al., 2012). Elevated levels in cerebral spinal fluid, serum,
saliva, urine, and even amniotic fluid are considered biomarkers for certain medical
circumstances, including concussion. High levels of S100B in these conditions grant an overall
indication of cell damage.
S100B post-injury. The primary clinical role of S100B in concussion management has
been to help identify intracranial hemorrhage on head CT scans, it is estimated that about 5% of
concussion patients will experience this (Kiechle et al., 2014). Even though the specificity of
S100B is low, the high sensitivity has led to several countries adopting the use of S100B as a
clinical tool to screen for abnormal head CT (Bazarian et al., 2013; Unden & Romner, 2010).
Yet, a significant overlap in S100B levels between controls and concussed athletes has
dampened the enthusiasm towards using S100B to aid in the diagnosis of concussion. Based on
comparisons between these groups, only very high S100B levels are considered abnormal – a
rarity post-concussion.
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One study found significantly elevated levels of S100B at 3 hours following sportsrelated concussion in comparison to baseline, but did not find differences at 2, 3, or 7 days postinjury (Kiechle et al., 2014). Another study assessed S100B within 6 hours following injury to
determine how many individuals tested positive for 0.1 ng/ml S100B or higher. Of their 102
patients who had suffered a concussion, not limited to sports-related, 72.5% tested positive
(Morochovic et al., 2009). Morochovic et al. (2009) suggest that 6 hours post-injury may be too
long of a timeframe between injury and blood collection due to S100B’s short half-life, rather
using three hours similar to Kiechle and colleagues (2014) could increase the sensitivity of the
measures.
Effects of exercise on S100B. Dang and colleagues (2014) suggest that S100B is related
to exercise. Hence, it may be specific to concussion because of the high prevalence in sports
(Dang et al., 2014). An issue is that S100B has been found to increase following head injury, but
exercise has also been shown to have this effect on S100B, making it hard to determine what is
causing this change (Hasselblatt et al., 2004; Stalnacke et al., 2003, 2004). A review completed
in 2014 identified more than nine forms of physical activity – they noted a trend in which
vigorous exercise might be the cause of increased S100B levels (Schulte et al., 2014). However,
Schulte et al (2014) also mentioned levels greater than 0.1 ug/L without a concussion clearly
stand out in data analysis. Some of those groups included professional or amateur soccer, ice
hockey, trained swimmers, and runners, etc. Two previous studies evaluating professional
athletes discovered higher than normal baseline measures of their participants prior to data
collection (Michetti et al., 2012; Stalnacke et al., 2003). These higher levels are most likely due
to the stressful conditions involved with high intensity physical training. Exercise influences
S100B based on the intensity, but further research is needed to assess dual/multi-sport athletes,
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and length of sport play, i.e. the amount of time someone has been playing hockey could
influence their S100B levels more than someone who hasn’t been playing for as long. However,
depending on the study, the timing of sample collection varied from immediately before and
after exercising to also include exercise programs taking blood samples on days one and ten
training, not just following concussion.
The variability of the studies in the Schulte et al (2014) review make it hard to decipher
what the actual effect exercise may have on S100B, especially in regards to sports-related
concussion. These differences need to be further accounted for, but overall lead to the general
consensus that exercise does affect S100B levels in the body. It is also unclear as to how long a
protein such as S100B may take to reach normal levels following a period of no exercise similar
to the return-to-play timeframe that a concussed athlete would endure. Since exercise is likely to
play a large effect on S100B or proteins alike it could be possible that athletes will never fit a
normal range of protein levels even following retirement compared to the general population due
to the body’s high exposure to rigorous training. These concepts should be considered when
studying head injury, because exercise is a component that has the potential to affect more than
just protein levels, but also mental health i.e., anxiety, stress, etc., in the entire active population
rather than solely athletes. Knowing the effect of exercise would increase the likelihood of an
individualized recovery plan for all people following head injury.
Ubiquitin C-Terminal Hydrolase L1. UCH-L1 is an abundant neuron-specific enzyme
accounting for 1%-%5 of total soluble brain protein (Mondello et al., 2014). UCH-L1 is a protein
involved in the augmentation and removal of ubiquitin metabolism-specific proteins
(Tongaonkar et al., 2000). UCH-L1 has a vital role in the removal of oxidized, misfolded, or
excessive proteins during normal and pathological conditions including TBI (Gong & Leznik,
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2007). Under pathological conditions UCH-L1 is released into extracellular space as a
consequence of cell destruction (Mondello et al., 2014). UCH-L1 can be measured in serum and
cerebral spinal fluid directly proportional to injury severity (Mondello et al., 2014). Based on
these characteristics UCH-L1 is a good candidate to be a biomarker for TBI.
UCH-L1 post-injury. Studies evaluating serum-based UCH-L1 following TBI remain
uncertain and much has to do with the lack of research conducted utilizing UCH-L1. In part due
to the recent discovery of UCH-L1 as a potential biomarker for TBI. A few studies have
suggested that UCH-L1 is increased following concussion compared to controls, however, some
previous findings have not found any differences in serum-based UCH-L1 levels (Diaz-Arrastia
et al., 2014; Kou et al., 2013; Papa et al., 2012; Puvenna et al., 2014). Kobeissy et al (2006)
assessed the subsequent effects of an induced TBI on a rat model described a two-fold increase
UCH-L1 in the injured cortex two days post-injury (Kobeissy et al., 2006). Another study
utilizing a rat model for TBI used a respective enzyme-linked immunosorbent assay (ELISA) to
assess UCH-L1, they found significant levels of cerebral spinal fluid and serum UCH-L1 as early
as two hours following injury (Liu et al., 2010). In regards to clinical research, a review found
that UCH-L1 has shown increases in non-sports related concussion in comparison to healthy
controls (Li et al., 2015). Previous research was able to detect significant elevations of UCH-L1
in human cerebral spinal fluid early after injury and found the levels to stay elevated for over a
week following injury (Brophy et al., 2011; Papa et al., 2010).
One of the first studies assessing UCH-L1 conducted by Papa et al (2012) found a
significant difference between the concussed group and uninjured controls, there was also a
significant difference between the concussed and trauma patients (Papa et al., 2012). The trauma
patients in this study were classified as those with non-head trauma used as a second control
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group. If researchers were able to identify a traumatic intracranial lesion on a head CT scan in
either the concussed or trauma groups, the UCH-L1 levels were significantly higher than those
whose CT scan was negative (Papa et al., 2012). Furthermore, the concussed patients who had a
negative CT scan exhibited significantly higher levels compared to the trauma patients who also
had a negative CT scan (Papa et al., 2012). The patients in this study who had a neurological
intervention also had substantially significant elevated levels of UCH-L1 compared to those who
did not (Papa et al., 2012). This pattern suggests that even without a positive CT scan or a
medical intervention it is still possible to have significantly higher levels of UCH-L1 following a
concussion. UCH-L1 has not yet been implicated in clinical purposes (i.e. diagnosis, etc.) due to
the unease surrounding its effectiveness in studies pertaining to diagnosis and treatment
outcome.
Effects of exercise on UCH-L1. No research was found pertaining to protein-based
UCH-L1 levels and exercise conducted in either humans or animals. However, an animal model
study conducted recently in 2018 assessing mRNA levels of UCH-L1 randomly divided rats into
an aerobic exercise and sedentary control groups (Liu et al., 2018). Over the course of 10 weeks
maximum oxygen consumption (VO2max) was gradually increased from 50%-55% to 65%-70%
(Liu et al., 2018). Although they were assessing levels of mRNA a significant upregulation of
UCH-L1 was discovered in the exercise group compared to the sedentary group after completing
ten weeks. W. Liu and colleagues (2018) suggest that consistent aerobic exercise modulates
proteins involved with striatum and mitochondrial development-related signaling transduction
proteins. These results are promising, but more research is needed to clarify which mechanisms
are causing this significant effect. A study like this also needs to be conducted using human
subjects. Translational research is important to grant a better depiction of the effects exercise has
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on UCH-L1 as a whole. UCH-L1 and exercise is a poorly studied area of research, more is
needed to recognize the effects of exercise at a protein level.
Tau. In response to a concussion, axons are most susceptible to damage. Tau is an
intracellular, microtubule-associated protein that is extremely abundant in axons and is involved
with building axonal microtubule bundles (Teunissen et al., 2005). Although primarily abundant
in axons, Tau can also be in cell bodies and dendrites. There are two molecular weights for Tau,
low forms are found in the brain and high forms are typically found in the spinal cord and
peripheral nervous system (Spittaels et al., 1999). Tau experiences several posttranslational
modifications – phosphorylation being the most dominant (Caprelli et al., 2019). When a severe
TBI takes place, Tau becomes hyperphosphorylated resulting in a release of Tau from
microtubules (Caprelli et al., 2019). This eventually alters the affinity of Tau causing it to
aggregate and form neurofibrillary tangles (Caprelli et al., 2019). Potentially leading to chronic
traumatic encephalopathy following several TBIs. Tau is most known for its role in Alzheimer’s,
but the distribution is different than in TBI in which differences have been found in relation to
various types including a single injury and repetitive head injury (Barrio et al., 2015). Tau can be
measured in three different forms creating inconsistencies in the literature; cleaved-Tau (C- Tau),
phosphorylated-Tau (P-Tau), and total-Tau (T-Tau).
Tau post-injury. In T-Tau, previous research has seen a significant increase in levels
when concussed athletes were compared to their own preseason measures, yet we don’t know
what T-Tau levels are after a concussion when compared to matched controls (Randall et al.,
2013). Similarly, a 2018 study conducted blood samples to assess levels of Tau to determine
differences between pre-season and post-injury (Shahim et al., 2018). Researchers found plasma
Tau to be higher one hour following injury in comparison to their pre-season measures. Tau was
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the same result when compared to non-athletic controls, but not when compared to their gymnast
control group (Shahim et al., 2018). Shahim and colleagues (2018) also noted Tau decreased 12
hours following injury, but saw an increase 7 days following injury, there after levels
normalized. In comparison to the length of return-to-play, plasma Tau levels had no effect,
however, this study did not indicate which type of Tau they were evaluating. (Shahim et al.,
2018).
Kawata et al (2018) also evaluated plasma Tau as well as sub-concussive hits during
practice in collegiate football players. Levels of Tau were independent of the number and
severity of sub-concussive hits to the head (Kawata et al., 2018). Plasma levels experienced the
highest increase after non-contact practice compared to the three contact practice time points.
The levels surprisingly decreased over time following the non-contact practice (Kawata et al.,
2018). Authors did not give any specific reasoning for these findings.
An animal study conducted by Gabbita and colleagues (2005) discovered increased levels
of C-Tau in the hippocampus of TBI-induced rats, but did not find any significance in
comparison to controls. Although there was no significant group difference, they did find C-Tau
levels to increase in the hippocampus as the severity of injury increased (Gabbita et al., 2005).
These researchers also evaluated cortical levels of C-Tau which also increased in response to an
induced TBI (Gabbita et al., 2005).
Effects of exercise on Tau. Unsurprisingly, a majority of research on exercise and Tau
relates to its role in Alzheimer’s development and direction over time. Unlike Alzheimer’s, the
research that has been conducted on exercise is mostly studied with animal models and very little
is assessed clinically. A large human study divided 103 participants into four subgroups; young
sedentary, young athlete, older sedentary, and older athlete (Daniele et al., 2018). Age did not
35

have a significant effect on Tau platelet concentrations (Daniele et al., 2018). The population as a
whole showed the athletes having significantly lower Tau levels in the platelet concentrations
compared to the sedentary individuals (Daniele et al., 2018). As the only study on exercise and
Tau this study is extremely difficult to replicate as the type of Tau measured is not specified nor
is one type of fitness test a good indicator of someone’s physical activity.
Biomarkers and Imaging. Even with the increase in protein-based biomarker research
and a profound amount of studies utilizing different neuroimaging techniques following TBI,
there are few studies assessing these measures together. This is particularly true in regards to
sports-related concussion in humans as the time line following injury for both proteins and
imaging is relatively unknown. Studies that have been conducted previously use both animal
models and humans, however; they lack not only consistency, but also have many limitations
such as differences in time of day, failing to control for medication, and extremely small sample
sizes. These gaps in research make it difficult to gain a greater understanding of the potential
relationship between protein-based biomarkers and neuroimaging (Di Battista et al., 2018;
McMahon et al., 2015).
Di Battista and colleagues (2018) assessed the possible relationship between blood
biomarkers and cerebral blood flow in a small sample of athletes. Samples were collected on
average four days following injury. Recently concussed athletes exhibited greater differences in
biomarker and MRI findings compared to both control groups; athletes with a history of
concussion and athletes with no history of concussion (Di Battista et al., 2018). However, a
negative relationship was found between global cerebral blood flow and T-Tau comparing
concussed athletes and controls without a history of concussion. None of the other proteins
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assessed, including S100B and BDNF showed any significant anti-modulation between groups
(Di Battista et al., 2018).
Unlike Di Battista et al (2018), McMahon and colleagues (2015) assessed serum-based
GFAP and its breakdown products within 24 hours of TBI, 83% were classified as a concussion.
Researchers analyzed both initial CT scans and follow up (1-2 week) MRI scans in conjunction
with serum levels of GFAP. Significantly higher GFAP was found in those with a CT-positive
intracranial injury compared to those who had negative CTs (McMahon et al., 2015). However,
neither MRI positive or negative patients displayed any significance in regards to GFAP levels,
but levels were higher in those who were MRI-positive.
A portion of the large multi-cite TRACK-TBI study assessed the association between MRI
abnormalities in civilian patients with CT-negative TBI and plasma GFAP concentrations (Yue
et al., 2019). Blood samples were collected within 24 hours of injury and MRI scans were
collected within 7-18 days following injury. Traumatic intracranial abnormality on a MRI and
GFAP associations were dose dependent, 64% of patients in the highest GFAP concentration
quintile had abnormal MRI findings (Yue et al., 2019). Yue and colleagues (2019) also found
that the 43% of patients with negative CT scans had GFAP concentrations higher than the top
percentile of the control group, of those patients 46% had an abnormal MRI. Even supposing
these findings were from sports-related concussion, these results are vague and do not give direct
insight as to the precise areas of these abnormalities. Knowing the exact areas of concussionrelated injury would result in a more thorough analysis ultimately leading to a more personalized
recovery.
Davies and colleagues (2019), collected 1-4 serum samples from semi-professional and
professional athletes at different points post-injury. These samples were used to assess UCH-L1,
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GFAP, NF-L, Tau, and miR-502, a serum microRNA following concussion. All participants
were symptomatic at the time of testing. Even though the researchers found significantly higher
levels miR-502 the farther the participants were from injury, they failed to assess the serum
samples further with the MRI scans that were collected as a part of the study instead they chose
to focus on the behavioral results (Davies et al., 2019). Several limitations existed, primarily the
sample being almost entirely male athletes from the same sport. Many studies like this collect
protein levels and neuroimaging, but never analyze both together.
There are more differences than similarities in TBI studies, specially sports-related
concussion. In order to improve diagnosis and recovery of concussion we first need to have
multi-modal studies including the use of proteins (or mRNA) and neuroimaging. Only studying
one measurement or the other will not grant a full depiction of concussion as what is negative on
a scan could be detrimental in terms of blood-based protein levels. Biomarker research needs to
expand to include neuroimaging of both CT and MRI scans. This project aims to close the gap by
assessing the differences between four specific serum-based protein biomarkers and MRI post
return-to-play. The goal is to add to previous findings whilst continuing to strive for consistency
in this realm of concussion research. To the best of our knowledge, we are the first to analyze
proteins in conjunction with GMV and FC measures following sports-related concussion.
Specific Aims
The purpose of this thesis is to establish serum-based biomarkers for lingering postconcussive effects in BDNF, S100B, UCH-L1, and Tau as an assessment of post return-to-play
in recently cleared concussed athletes. We aim to see changes in the structural and functional
brain networks of the concussed group compared to the control group. We also aim to compare
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MRI findings, both structure using gray matter volume and functional connectivity to the BDNF,
S100B, UCH-L1, and Tau levels collected through serum samples.
Therefore, this thesis hypothesizes that each protein will have an effect of group. We expect
that higher levels of S100B and Tau protein will be expressed in the concussion group in
comparison to the control group similar to what we have previously found with BDNF.
However, we expect the concussed group to express lower levels UCH-L1 compared to the
control group. In addition, we hypothesize that there will be differences in the concussed and
control groups in FC and GMV in the following areas: brainstem, prefrontal cortex, and
hippocampus. Further, we also hypothesize that alterations in protein levels will be linked to
differences found in FC and/or GMV between groups in the same areas as above. We expect to
see these alterations based on the differences in protein levels between the concussed and control
groups that have been known to exist. The proteins with the highest level of significance between
groups are thought to exhibit FC and/or GMV changes.

Methods
Participants
Forty-two collegiate athletes between the ages of 18 and 22 from Northern Michigan
University’s athletic programs participated in this study. Half (n = 21) were recently cleared by
an athletic trainer and/or physician to return-to-play after sustaining a concussion. The other half
(n = 21) of the participants were controls without a history of concussion in the 36 months
preceding the study. Controls were matched on age, sex, sport, and time of sample collection
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(see Table 1). All participants gave informed consent and were monetarily compensated for their
time and effort.
Procedure
Every participant gave a 5 ml. blood sample, completed the Depression Anxiety Stress
Scales (DASS) Questionnaire. A subgroup of 30 participants underwent a one-hour MRI scan
(15 concussed, 15 control). Participants in this study also completed the ImPACT test, three
tasks using Near Infrared Spectroscopy, a device measuring hemoglobin levels over the
prefrontal cortex, including a resting state task, and gave a 2 ml. saliva sample. However, the
findings of those measures will not be assessed in this thesis. DASS and blood samples were
done prior to the MRI. The MRI scan consists of ten different types of scans, including a
calibration scan, a diffusion tensor imaging (DTI) scan, a diffusion weighted imaging (DWI)
scan, two fMRI scans as well as a few types of structural scans. However, for this thesis we will
be focused on; the structural T1 and resting state fMRI scans.
DASS
DASS consists of three self-report subscales designed to measure levels of depression,
anxiety, and stress (Lovibond & Lovibond, 1995). Each scale consists of 14 statements on a 4point rating scale ranging from 0-3, for a total of 42 items. Participants were asked to answer the
statements based on the degree to which they experienced each statement over the past week.
The total score for DASS ranges from 0-126. This questionnaire was used for further analysis
between groups, because concussion is linked to elevated symptoms of anxiety and depression
(Moore et al., 2006).
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ImPACT
The ImPACT test is a widely used baseline assessment on neurocognitive performance to
assist in medical clearance for sports-related concussion. One of the components is the PCSS, a
22 self-report item scale measuring concussion-related symptom. This scale was used to assess
each participant’s level of symptom severity. It has a 7-point scale ranging from 0-6.
Serum
Blood samples were collected in 5 ml. vacutainer serum separator tubes (Becton
Dickinson, Franklin Lakes, NJ), by a trained phlebotomist in the Department of Clinical
Laboratory Sciences. Following collection, the serum separator tubes were immediately inverted
four times and allowed to clot for 30 minutes at room temperature. Serum was separated via
centrifugation at 3,500 rpm for 10 minutes and 1ml aliquots will be transferred to sterile 2 ml.
cryovials (Nalgene, Rochester, NY). Samples were stored at −80 °C until further use. After
thawing, samples were centrifuged one more time to ensure all debris had been removed.
Saliva
Saliva was collected by the passive drool method, because it is known to detect higher
levels of BDNF when compared to the salivette method. After pooling saliva in their mouth,
participants used the saliva collection aid to force the saliva into a vial. At least 2.0 ml of saliva
was collected from each participant. Samples were placed on ice immediately until further
handling. All samples were centrifuged for 15 minutes at 4000 rpm to 4⁰C. Consistent with
serum sample, saliva samples were stored at -80⁰C until analysis.
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Protein Analysis
BDNF ELISA Assay
Both saliva and serum BDNF levels were analyzed using an enzyme-linked
immunosorbent assay (ELISA) kit (CYT306, Millipore Sigma). Assay of saliva samples were
not diluted while serum samples were diluted to a 1:32 ratio. Each assay was performed in
duplicate. ELISA plate readings were performed using a microplate reader (Epoch2; BioTek
Instruments, Inc., Winooski, VT, USA). Analysis was performed using Gen5 software (BioTek
Instruments, Inc., Winooski, VT, USA). Standard curves were obtained for saliva (R2 = .992)
and serum (R2 = .995).
S100B, UCH-L1, & Tau ELISA Assays
S100B levels were analyzed using a same day ELISA kit (EZHS100B-33K, Millipore
Sigma). UCH-L1 and Tau levels were analyzed using an ELISA kit (RAB1766; RAB1085,
Millipore Sigma). UCH-L1 serum samples were diluted a 1:2 ratio, Tau serum samples were
diluted a 1:3 ratio, and S100B serum samples were not diluted. Every sample for each assay was
performed in duplicate. ELISA plate readings were performed using a microplate reader
(Epoch2; BioTek Instruments, Inc., Winooski, VT, USA). Analysis was performed using Gen5
software (BioTek Instruments, Inc., Winooski, VT, USA). A standard curve was obtained for
each protein respectively; S100B (R2 = .991)., UCH-L1 (R2 = .945)., and Tau (R2 = 1.0;
degradation occurred by the time all the samples were assessed so re analysis is needed).
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Magnetic Resonance Imaging
MRI Acquisition
A 1.5 Tesla General Electric MRI scanner located at the Upper Peninsula Health System
Marquette Hospital will be utilized for all scanning purposes. The staff at the hospital conducted
all of the scans and each scan should have lasted no longer than 45 minutes. Prior to beginning
scanning participants were questioned about metal implants and claustrophobia to ensure safety
of participants and quality of scan. Once ready, participants were instructed to relax, keep their
eyes closed, and to not move other than breathing. This thesis is focusing primarily on two main
types of scans; for structural purposes including GMV, the T1 weighted scan is being used and
an fMRI scan is being used to assess FC in the brain. We examined a T1 weighted scan, (TR =
567.0 ms; TE = Min Full; flip angle = 45; 28 slices, FOV = 22.0 mm) and a resting state T2*
fMRI scan with 240 volumes, (TR = 2500 ms; TE = 35.0; flip angle = 90; 150 volumes, matrix =
64 x 64; FOV = 22.0 mm; total scan time = 6.25 min).
MRI Preprocessing
Structural Data. Structural pre-processing measures was run through Statistical
Parameter Mapping 12 (SPM12), an extension of MatLab (2019b version). Prior to beginning
pre-processing the DICOM files from each MRI scan were first imported from CD disks burned
off the MRI scanner from the staff at the hospital. Once these files were imported they were
converted into NIfTI files specifically meant for anatomical and functional analysis, through a
program called MRIcroGL. At this point the data was ready for pre-processing in SPM12. The
following steps were done to pre-process the structural data in SPM12: (1) segmentation into six
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different components; GMV, white matter, cerebral spinal fluid, skull, soft tissue, other; (2)
unwarping; (3) normalization to MNI-152; and (4) smoothing with an 8mm smoothing kernel.
Segmentation is the process of segmenting the images into gray matter, white matter, and
cerebral spinal fluid, for this project we are mainly focused on gray matter. Unwarping adjusts
the images to correct for any distortions caused by the magnetic field of the scanner. This
process attempts to return the image to the actual brain shape. Normalization is done to transform
one brain to match shape with another, because people have different shaped brains allowing
group analyses to be transformed into the same space. The normalization step in SPM utilizes the
Montreal Neurological Institute 152 template. Smoothing is also known as spatial averaging;
each voxel is replaced with a weighted average of the values in surrounding voxels. This step
increases the signal to noise ratio and tends to reduce any random noise due to averaging.
Functional Data. The use of CONN, a FC toolbox, an extension of Matlab was utilized
to examine FC of all participants (Whitfield-Gabrieli and Nieto-Castanon, 2012). Functional data
was pre-processed with the following steps in CONN: (1) realignment and unwarp, (2) center,
(3) slice time correction, (4) outlier detection, (5) functional segmentation, (6) functional
normalization, (7) structural segmentation, (8) structural normalization, and (9) smoothing with
an 8mm smoothing kernel.
Realignment is used to adjust the series of images in order to keep the brain always in the
same orientation by aligning them to the center voxel (0,0,0). This needs to be done because
people move their heads. Slice time correction adjusts the image to make it appear that all of the
slices were acquired at the same time. Our scans were collected in slices meaning they were all
acquired at different times making it important to use slice time correction. Outlier detection is to
access any outlaying objects or artifacts within the scans.
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Table 1. Comparison of Participant Groups Adapted from (Susa et al., 2019 & Carlson et al., 2020)
Concussion
Control
Comparison
N
Age

21
M = 19.67, SD = 1.39

21
M = 19.67, SD = 1.11

Sex

Female = 8, Male = 13

Female = 8, Male = 13

Days since RTP
Days since concussion

M = 9.71, SD = + 12.08
M = 26.82, SD = + 13.10

---

# of concussions
PCSS T

M = 1.81, SD = 0.98
M = 8.95, SD = 11.66
(n = 20)

M = 0.33, SD = 0.73
M = 2.60, SD = 3.72
(n = 20)

DASS D

M = 8.05, SD = 7.45

M = 2.90, SD = 5.06

DASS A

M = 8.95, SD = 8.05

M = 2.62, SD = 2.91

DASS S

M = 11.19, SD = 8.91

M = 4.48, SD = 5.06

DASS T
Intake prior to data
collection

M = 28.19, SD = 22.20
Nicotine = 2, OTC = 1,
Caffeine = 5

M = 10.00, SD = 10.70
Nicotine = 2, OTC = 5,
Caffeine = 7

Time of sample

M = 13.40, SD = 3.42

M = 13.15, SD = 2.64

Sport

USA Wrestling = 2

USA Wrestling = 2

Football = 6
Diving = 2

Football = 6
Diving = 2

Soccer = 6
Club Hockey = 2

Soccer = 6
Club Hockey = 2

Club Volleyball = 1
Swimming = 2

Club Volleyball = 1
Swimming = 2

t(38) = 2.32, p =
0.026
t(40) = 2.62, p =
.01
t(40) = 3.39, p <
.01
t(40) = 3.00, p <
.01
t(40) = 3.38, p <
.01

t(40) = .265, p =
.792

RTP = return-to-play

Data Analysis
DASS Questionnaire
T-tests were used to assess the effect of group on each of the three DASS subscales;
depression, anxiety, stress, and composite score (mTBI vs. control).
Proteins
Brain Derived Neurotrophic Factor. Of the 42 participants, 39 yielded data for the
serum analysis, 36 for the saliva analysis, and 35 participants had both serum and saliva data.
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Separate analyses of covariance (ANCOVA) were used to test the effect of concussion group on
serum and salivary BDNF while controlling for negative affect (i.e., DASS) as symptoms of
depression, anxiety, and stress have been previously found to be elevated following concussion.
As an exploratory component additional analyses were conducted. Single-tailed Pearson
correlations were used to test for a (positive) relationship between serum and salivary BDNF
measures across the entire sample as well as separately for each group. Pearson correlations were
also used to test for a relationship between BDNF levels and days since concussion and days
since return-to-play.
S100B, UCH-L1, & Tau Analysis. Of the 42 participants, 34 yielded data for the S100B
analysis, 36 for the UCH-L1 analysis, and 35 participants for Tau analysis. Separate ANCOVAs
were used to test the effect of the concussion group on serum levels of S100B, UCH-L1, & Tau
while controlling for negative affect (i.e., DASS). Pearson correlations were used to test for a
relationship between serum levels and days since concussion and days since return-to-play in the
concussion group.
MRI measures
Gray Matter Volume. Voxel based morphometry (VBM) analysis used a regression
model with group and protein as potential predictors of whole brain GMV. The following
covariates were included in the regression model; age, sex, DASS-T, and intracranial volume
(ICV). Main effects and interactions were assessed at the .005 significance level.
Functional Connectivity. We used regression models with group and protein as
predictors of FC based on hippocampus, brainstem, salience lateral prefrontal cortex, and
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frontoparietal network seeds at the 0.001 significance level. For this thesis we utilized ROI-toVoxel based FC.
Results
Return to play & days post-injury
There was no significant relationship between days since concussion and days since
return-to-play in the concussion participants, r = .30, p = .20 (see Table 1).
DASS Questionnaire
The concussion group exhibited significantly higher levels of depression, anxiety, stress,
and total DASS measures compared to the control group (see Table 1).
Hypothesis one: We expected each protein to have an effect of group.
BDNF Serum
As reported in Susa et al., (2019) there was an effect of group on serum BDNF levels,
F(1, 36) = 4.13, p < .05, ηp2 = .10, where concussion participants (M = 2.0 ng/ml, SE = .099) had
greater levels of BDNF than controls (M = 1.70 ng/ml, SE = .096). The total DASS score was not
related to serum BDNF levels, F(1, 36) = 1.00, p = .32, ηp2 = .03. For concussion participants, the
relationships between serum-based BDNF and time since return-to-play (r = .19, p = .46) as well
as time since injury (r = -.02, p = .95) were not statistically significant.
BDNF Saliva
As reported in Susa et al., (2019), observations of box and whisker plots indicated three
outliers (2 concussion & 1 control) that were > three SDs above the respective group M. These
outliers were excluded from all analyses involving saliva. There was no effect of group on
salivary BDNF levels, F(1, 30) = .36, p = .55, ηp2 = .01. BDNF levels in concussion participants
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(M = .11 ng/ml, SE = .02) did not differ from control participants (M = .09 ng/ml, SE = .02). The
total DASS score was not related to salivary BDNF levels, F(1, 30) = .16, p = .70, ηp2 = .00. In
the concussion group, a strong positive correlation was found between salivary BDNF and time
since return-to-play, r = .69, p = .004. However, no such correlation was found between salivary
BDNF and time since injury, r = .05, p = .87.
S100B
There was not an effect of group on S100B levels, F(1, 31) = .008, p = .93, ηp2 = .00.
Concussion participants’ S100B levels (M = .090 ng/ml, SE = .005) did not differ from controls
(M = .090 ng/ml, SE = .005). The total DASS score was not related to S100B levels, F(1, 31) =
.016, p = .90, ηp2 = .00. For concussion participants, the relationships between S100B and time
since return-to-play (r = .22, p = .41) as well as time since injury (r = .03, p = .90) were not
statistically significant.
UCH-L1
There was not an effect of group on UCH-L1 levels, F(1, 31) = 2.05, p = .16, ηp2 = .06.
Concussion participants’ UCH-L1 levels (M = .73 ng/ml, SE = .271) did not differ from controls
(M = 1.32 ng/ml, SE = .271). The total DASS score was not related to UCH-L1 levels, F(1, 33) =
1.14, p = .29, ηp2 = .03. For concussion participants, the relationships between UCH-L1 and time
since return-to-play (r = .35, p = .17) as well as time since injury (r = .32, p = .19) were not
statistically significant.
Tau
The effect of group on Tau levels did not reach significance, F(1, 32) = 3.65, p = .07, ηp2
= .10, but there was a trend where concussion participants Tau levels (M = 1.39 ng/ml, SE =
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.309) tended to be lower than controls (M = 2.30 ng/ml, SE = .320). The total DASS score was
not related to Tau levels, F(1, 32) = 1.94, p = .17, ηp2 = .06. For concussion participants, the
relationship between Tau and time since return-to-play (r = .39, p = .12) was not statistically
significant. However, the relationship between Tau and time since injury (r = .58, p = .01) was
statistically significant. The more time that had elapsed since injury the higher the Tau levels
(see Figure 2).

Tau vs Days Since Injury
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Figure 2. Tau and days since injury. The correlation between days since injury and serum Tau
levels in the concussed group.
MRI Subset
Of the 30 participants that underwent an MRI scan, 26 were used for analysis (13
concussion and 13 control). A total of four were excluded from all analyses, two were excluded
due to technical issues with their MRI scan (1 concussion and 1 control), the other two were
excluded due to no blood data (1 concussion and 1 control; see Table 2). However, only 25 were
included for the Tau analysis due to running out of sample for one of the participants (1 control).
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Table 2. Comparison of Participant Groups (MRI Subset)
Concussion

Control

N

13

13

Age

M = 19.46, SD = 1.27

M = 19.46, SD = 0.88

Sex

Female = 6, Male = 7

Female = 6, Male = 7

DASS T

M = 35.92, SD = 24.14

M = 8.31, SD = 11.0

Intake prior to data
collection

Nicotine = 1, OTC = 0,
Caffeine = 3

Nicotine = 1, OTC = 3,
Caffeine = 5

Time of sample

M = 13.10, SD = 3.26

M = 12.81, SD = 2.34

Sport

USA Wrestling = 1

USA Wrestling = 1

Football = 5

Football = 5

Diving = 2

Diving = 2

Soccer = 3

Soccer = 3

Club Hockey = 1

Club Hockey = 1

Swimming = 1

Swimming = 1

Comparison

t(24) = 3.75, p =
.001.

t(24) = .259, p =
.798

Hypothesis two: There would be differences in FC and GMV between concussed and
control groups in the following areas: brainstem, prefrontal cortex, and hippocampus.
Gray Matter Volume
There was no main effect of group on GMV at an FDR adjusted cluster level (p < .05)
analysis, however a main effect of group on GMV was observed at the peak level uncorrected (p
= .001). GMV was found to be greater in the concussion group relative to the control group in
the superior frontal gyrus, superior temporal gyrus, post central gyrus, calcarine fissure and the
surrounding cortex (see Table 3). The concussion group also exhibited lower GMV compared to
the control group in the lingual gyrus and the calcarine fissure and surrounding cortex. (see
Table 3).
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Figure 3. Group differences: higher GMV. Concussed participants exhibited significantly higher
GMV in the calcarine fissure & surrounding cortex (left) and superior frontal gyrus (right)
relative to the controls.

Figure 4. Group differences: lower GMV. Concussed participants displayed significantly lower
GMV in the calcarine fissure & surrounding cortex (left and middle) and the lingual gyrus
(middle and right) in comparison with the control group.
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Table 3. Group Differences in GMV
Concussion > Control
Region
Superior frontal gyrus/Dorsolateral
Superior frontal gyrus/Orbital
Superior Temporal Gyrus
Postcentral Gyrus
Calcarine Fissure and Surrounding Cortex
Control > Concussion
Region

Hemisphere

kE

Right
Left
Left
Right
Right

96
70
38
61
43

Hemisphere

kE

Lingual Gyrus

52

Calcarine Fissure and Surrounding Cortex
All differences significant at p < .001 uncorrected

Left

21

t-value
5.20
5.03
4.56
4.01
3.79

Coordinates (xyz)
23, 39, 39
-27, 51, -3
-41, 6, -18
36, -26, 47
6, -65, 17

t-value
5.11
4.06

Coordinates (xyz)
-6, -68, -3
-2, -96, -6

Functional Connectivity
There was no main effect of group on FC at an FDR adjusted cluster level (p < .05)
analysis, however a main effect of group on FC was observed at the peak level uncorrected (p =
.001) in each of the selected CONN-based seeds. Stronger connectivity was observed in the
hippocampus between the middle temporal gyrus and inferior temporal gyrus in the concussion
group. Weaker connectivity was observed between the hippocampus with the cerebellum and
postcentral gyrus in the concussion group (see Table 4).

Figure 5. Group differences: left hippocampus FC. Weaker connectivity in the concussed group
was observed between the left hippocampus seed with the postcentral gyrus and white matter
(left). Stronger connectivity in the concussed group was observed between the left hippocampus
seed and the inferior temporal gyrus (right).
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Figure 6. Group differences: right hippocampus FC. Weaker connectivity in the concussed group
was observed between the right hippocampus seed and the cerebellum (left). Stronger
connectivity in the concussed group was observed between the right hippocampus seed and the
middle temporal gyrus (right).

Stronger connectivity in the concussion group was observed between the brainstem and
the insula, middle frontal gyrus, middle cingulate and paracingulate gyri. No weaker connections
between the brainstem and any region of the brain was observed (see Table 4).

Figure 7. Group differences: brainstem FC. Stronger connectivity in the concussed group was
observed between the brainstem and with the insula (left and right), middle cingulate cortex
(left), and middle frontal gyrus (left).

Stronger connectivity was observed in the salience right prefrontal cortex (RPFC)
between the brainstem, supplementary motor area (SMA), and cerebellum in the concussion

53

group. A weaker connection in the concussion group was observed in the salience RPFC
between the inferior temporal gyrus, superior and middle frontal gyri, gyrus rectus, and the
cerebellum (see Table 4).

Figure 8. Group differences: left salience stronger FC. Stronger connectivity in the concussed
group was observed between the left salience RPFC with the SMA (left), cerebellum (right), and
brainstem (right).

Figure 9. Group differences: left salience weaker FC. Weaker connectivity in the concussed
group was observed between the left salience RPFC with the gyrus rectus/ventromedial
prefrontal cortex (left and right) and the inferior temporal gyrus (right).
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Figure 10. Group differences: right salience FC. Stronger connectivity in the concussed group
was observed between the right salience RPFC with the cerebellum (left and right) and white
matter (left).

Stronger connectivity in the concussion group was observed in the frontoparietal left
prefrontal cortex (LPFC) between the superior temporal gyrus, lingual gyrus, precuneus,
cerebellum, and the calcarine fissure and surrounding cortex. The concussion group exhibited
weaker connections in the frontoparietal LPFC between the angular gyrus, middle and inferior
frontal gyri (see Table 4).

Figure 11. Group differences: left frontoparietal stronger FC. Stronger connectivity in the
concussed group was observed between the left frontoparietal LPFC with the precuneus (left),
superior temporal gyrus (right), calcarine fissure and surrounding cortex (left and right).

55

Figure 12. Group differences: left frontoparietal weaker FC. Weaker connectivity in the
concussed group was observed between the left frontoparietal LPFC and the orbitofrontal cortex
(left and right).

Figure 13. Group differences: right frontoparietal FC. Stronger connectivity in the concussed
group was observed between the right frontoparietal LPFC and the cerebellum (left). Weaker
connectivity in the concussed group was observed between the frontoparietal LPFC and the
orbitofrontal cortex (right).
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Table 4. Group Differences in FC
Concussion > Control
Seed
Region
Hippocampus Right
Middle Temporal Gyrus
Hippocampus Left
Inferior Temporal Gyrus
Brainstem
Insula
Middle Frontal Gyrus
Middle Frontal Gyrus
Median Cingulate &
Paracingulate Gyri
Salience RPFC Left
Medulla
Supplementary Motor Area
Salience RPFC Right
Cerebellum
Cerebellum
Frontoparietal LPFC Left
Superior Temporal Gyrus
Superior Temporal Gyrus
Superior Temporal Gyrus
Cerebellum
Precuneus
Lingual Gyrus
Calcarine Fissure &
Surrounding Cortex
Frontoparietal LPFC Right Cerebellum
Control > Concussion
Seed
Region
Hippocampus Right
Cerebellum
Hippocampus Left
Postcentral Gyrus
Salience RPFC Left
Inferior Temporal Gyrus
Superior Frontal Gyrus
Cerebellum
Cerebellum
Gyrus Rectus
Middle Frontal Gyrus
Inferior Temporal Gyrus
Frontoparietal LPFC Left
Middle Frontal Gyrus
Inferior Frontal Gyrus
Angular Gyrus
Frontoparietal LPFC Right Inferior Frontal Gyrus
All differences significant at p < .001 uncorrected
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Hemisphere
Left
Right
Left
Left
Right

kE
29
51
65
101
39

t-value
4.29
4.80
5.94
4.76
4.67

Left

22

3.90

0, -26, 48

Left
Right

52
34
53
20
55
44
33
27
32
48

4.80
4.57
4.68
4.44
5.63
4.92
4.63
4.10
4.07
4.04

0, -38, -34
10, 14, 66
-26, -78, -32
16, -42, -18
42, -28, -2
-44, 22, -24
48, -8, -10
-6, -78, -14
-6, -48, 58
6, -84, -10

Left

67

3.87

2, -90, 8

72

4.58

38, -78, -28

kE
99
25
122
88
28
94
46
121
33
54
71
61
32

t-value
5.12
4.14
5.98
5.55
5.01
4.70
4.65
4.35
4.32
5.49
5.13
4.19
4.14

Right

Right
Left
Right

Hemisphere

Right
Right

Right
Right
Left
Right
Left
Right
Right

Coordinates (xyz)
-56, -30, -10
60, -10, -36
-32, 16, -4
-34, 36, 34
32, 26, 36

Coordinates (xyz)
-24, -30, -36
20, -36, 52
68, -26, -28
20, -12, 66
-46, -64, -50
46, -62, -44
8, 32, -22
44, 54, -4
-54, -42, -26
48, 16, 52
-18, 28, -20
60, -56, 34
22, 24, -20

Hypothesis three: Alterations in protein levels would be linked to differences in FC and/or
GMV between groups in the same areas as above.
Gray Matter Volume
BDNF. No FDR adjusted (p < .05) cluster-level differential relationships exist between
group for BDNF and GMV. However, relationships between group for BDNF and GMV do exist
when assessed at peak level uncorrected (p = .001; see appendix Table 6).
S100B. A differential relationship was observed between groups for S100B and GMV at
an FDR adjusted (p < .05) cluster level in the insula where the association between S100B and
GMV was more positive in the concussed group relative to the control group. Group moderated
the relationship between S100B and GMV in the cerebellum, supplementary motor area, superior
parietal gyrus, paracentral lobule, and the postcentral gyrus where the concussion group was
negative relative to the control group (see Table 5). More relationships between group for
S100B and GMV exist at an uncorrected (p = .001) peak level (see appendix Table 7).

Figure 14. Positive association, S100B and GMV. A differential relationship was observed
between S100B and GMV in the insula where the concussed group was more positive relative to
control (left and right).
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Figure 15. Negative association, S100B and GMV. A differential relationship was observed
between S100B and GMV in the postcentral gyrus (left), SMA (left), medial frontal gyrus (left),
paracentral lobule (left, superior parietal gyrus (left and right), and the cerebellum (left and right)
where the concussed group was more negative relative to control.

UCH-L1. A differential relationship between group for UCH-L1 and GMV was observed
at an FDR adjusted (p < .05) cluster level in the brainstem where concussion group was more
positive. No other cluster level differential relationships exist between group for UCH-L1 and
GMV (see Table 5). However, several relationships between group for UCH-L1 and GMV exist
at an uncorrected (p = .001) peak level (see appendix Table 8).

Figure 16. UCH-L1 and GMV. A differential relationship was observed between UCH-L1 and
GMV in the brainstem where the concussed group was more positive relative to control (left and
right).
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Tau. No FDR adjusted (p < .05) cluster-level differential relationships exist between
group for Tau and GMV. However, relationships between group for Tau and GMV do exist
when assessed at an uncorrected (p = .001) peak level (see appendix Table 9).
Table 5. GMV Cluster Level
Concussion > Control
Protein
Region
Hemisphere
S100B
Insula
UCH-L1
Brainstem
Control > Concussion
Protein
Region
Hemisphere
S100B
Supplementary Motor Area
Left
Paracentral Lobule
Right
Cerebellum
Postcentral Gyrus
Superior Parietal Gyrus
Right
Note. All differences significant at p < .05 corrected

kE
1011
417

p-value
0.000
0.001

Coordinates (xyz)
-32, -8, 14
-5, -18, -32

kE
428
386
804
501
366

p-value
0.020
0.026
0.003
0.016
0.027

Coordinates (xyz)
-2, 18, 65
12, -27, 78
-3, -50, -3
-21, -30, 72
26, -74, 57

Functional Connectivity
BDNF. FC between the left salience right prefrontal cortex seed with the cerebellum and
the middle frontal gyrus was weaker in the concussion group relative to the control group at an
adjusted (p < .05) cluster level (see Table 10). More relationships between group for BDNF and
FC exist at an uncorrected (p = .001) peak level (See appendix Table 11).
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Figure 17. BDNF and FC. A differential relationship was observed between BDNF and FC in
the left salience RPFC with the cerebellum (left) and the middle frontal gyrus (right) where the
concussed group displayed weaker connectivity relative to control.

S100B. FC between the left salience right prefrontal cortex seed with the inferior
temporal gyrus and the middle frontal gyrus was weaker in the concussion group relative to the
control group at an adjusted (p < .05) cluster level (see Table 10). More relationships between
group for S100B and FC exist at an uncorrected (p = .001) peak level (see appendix Table 12).

Figure 18. S100B and FC. A differential relationship was observed between S100B and FC in
the left salience RPFC with the cerebellum (left) and the middle frontal gyrus (right) where the
concussed group exhibited weaker connectivity relative to control.
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UCH-L1. No adjusted (p < .05) cluster-level differential relationships exist between
group for UCH-L1 and FC. However, relationships between group for UCH-L1 and FC do exist
when assessed at an uncorrected (p = .001) peak level (see appendix Table 13).
Tau. Group moderated the relationship between Tau and FC in the superior frontal gyrus,
middle frontal gyrus, and the medial superior frontal gyrus at an adjusted (p < .05) cluster level
in the hippocampus seeds where the concussion group was stronger. FC in the right
frontoparietal left prefrontal cortex with the cerebellum was also stronger in the concussion
group at an adjusted (p < .05) cluster level (see Table 10). No negative differential relationships
were observed between group for Tau and FC at an adjusted (p < .05) cluster level. More
relationships between group for Tau and FC exist at an uncorrected (p < .05) peak level (see
appendix Table 14).

Figure 19. Tau and left hippocampus FC. A differential relationship was observed between Tau
and FC in the left hippocampus with the middle frontal gyrus/middle superior frontal gyrus (left)
and the visual cortex (left and right) where the concussed group displayed stronger connectivity
relative to control.
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Figure 20. Tau and right hippocampus FC. A differential relationship was observed between Tau
and FC in the right hippocampus with the medial frontal gyrus (left), lingual gyrus (left) and the
superior frontal gyrus (right) where the concussed group displayed stronger connectivity relative
to control.

Figure 21. Tau and right frontoparietal FC. A differential relationship was observed between Tau
and FC in the right frontoparietal LPFC with the cerebellum (left and right) where the concussed
group displayed stronger connectivity relative to control.
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Table 10. FC Cluster Level
Concussion > Control
Protein
Tau

Seed
Hippocampus Right
Hippocampus Left

Frontoparietal LPFC Right
Control > Concussion
Protein
BDNF

Region
Superior Frontal Gyrus
Medial Superior Frontal Gyrus
Middle Frontal Gyrus
Medial Superior Frontal Gyrus
Cerebellum

Seed
Salience RPFC Left

Region
Cerebellum
Middle Frontal Gyrus
S100B
Salience RPFC Left
Inferior Temporal Gyrus
Middle Frontal Gyrus
All differences significant at p < .05 corrected

Hemisphere
Left
Left
Left

Hemisphere

kE
165
273
154
204
158

pvalue
0.016
0.003
0.029
0.017
0.045

Coordinates
(xyz)
-12, 26, 52
-6, 66, 2
26, 28, 32
-2, 54, 6
34, -78, -28

kE
131
146
158
175

pvalue
0.036
0.036
0.024
0.024

Coordinates
(xyz)
44, -62, -42
42, 54, -8
64, -26, -28
38, 60, -6

Discussion
Serum BDNF was elevated in collegiate athletes post return-to-play following a sportsrelated concussion relative to age, sex, and sport-matched controls. No significant difference was
found between groups for the other proteins: S100B, UCH-L1 and Tau or salivary BDNF. Tau
was significantly correlated with days since injury and salivary BDNF was significantly
correlated with days since return-to-play, but no other proteins displayed significant correlations
with either days since return-to-play or days since injury (see Figure 2). Overall, significant
differences were only observed in BDNF and Tau, not S100B or UCH-L1.
GMV and FC were assessed at both peak and cluster level. No group differences were
found at an FDR adjusted (p < .05) cluster level for GMV or FC. However, several main effect
of group differences were found in GMV and FC at an uncorrected (p = .001) peak level (see
Tables 3 & 4). Differential relationships were observed for S100B and UCH-L1 with GMV
between groups at an FDR adjusted (p < .05) cluster level (see Table 5). Additional observations
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of differential relationships were made for all proteins at an uncorrected (p = .001) peak level for
GMV (see appendix Tables 6-9). BDNF, S100B, and Tau exhibited differential relationships at
an FDR adjusted (p < .05) cluster level between groups and FC (see Table 10). Several
additional differential relationships existed at an uncorrected (p = .001) peak level for all proteins
between group and FC (see appendix Tables 11-14). In summary, it appears that concussion is
associated with differences in brain structure and function (i.e. GMV and FC) as well as the
association between these measures and proteins.
Hypothesis one: We expected each protein to have an effect of group.
An effect of group was displayed in serum-based BDNF where the concussion group was
significantly elevated compared to controls. No other significant group differences were
observed in BDNF, S100B, UCH-L1, and Tau. Even though the main effect of group was not
significant in Tau, a trend was observed where the concussed participants tended to have lower
levels of Tau compared to the age, sex, and sport-matched controls. Significant correlations were
found between saliva-based BDNF and days since return-to-play as well as Tau and days since
injury.
Interpretation of findings
Serum BDNF. Our finding of significantly elevated serum BDNF in concussion post
return-to-play relative to control provides a better understanding of concussion at a biological
level in the return-to-play timeframe. Previous TBI biomarker research has been primarily
conducted in animals which showcase an initial reduction in BDNF immediately following
injury before later increasing (Kaplan et al., 2010). This later increase in protein BDNF
following TBI is thought to be a result of an increase in BDNF mRNA in the cortex (Griesbach
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et al., 2002). One small study with humans found similar results of increased BDNF directly
following severe TBI in children (Chiaretti et al., 2003).
BDNF is thought to play a major role in the reduction of secondary injury (Kaplan et al.,
2010). Secondary injury is a combination of apoptotic, inflammatory, and ischemic processes
following a direct primary TBI (Kaplan et al., 2010). Considering BNDF’s role in
neuroprotection and neurogenesis, previous research has suggested that the higher BDNF is
following injury, the more secondary injury is likely to be reduced (Griesbach et al., 2002;
Kaplan et al., 2010). Every sample for this project was collected after participants were
medically cleared to return-to-play, therefore, our protein levels are likely to serve as part of the
recovery or secondary injury phase. Thus, our finding of significantly elevated serum BDNF
suggests that despite symptoms subsiding and being cleared to return-to-play following a sportsrelated concussion, athletes’ brains are still healing.
Salivary BDNF. There was not a significant difference between groups for salivary
BDNF, however, serum and salivary BDNF related were related in the concussed group. A
strong significant correlation was found between saliva and days since return-to-play. This was a
positive relationship implicating the longer an athlete had been cleared to return-to-play the
higher their salivary BDNF. This null group effect indicates that even though there was not a
significant difference in salivary BDNF between concussed and control, this may still be a way
to assess recovery post-injury. In particular, the relationship between serum and salivary BDNF
in the concussed group is promising as saliva may be another way to evaluate sports-related
concussion. However, even with these novel findings salivary BDNF needs to studied at a larger
scale and involve other proteins to determine its potential as a biomarker for concussion.
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S100B. We did not find a significant difference between groups in S100B, rather
concussion was nearly identical to the control. Although we expected to find significantly
elevated measures of S100B in serum following injury, our finding that levels of serum S100B
did not differ across groups aligns with previous research (Kiechle et al., 2014; Michetti et al.,
2012; Morochovic et al., 2009). Elevated levels of S100B have been discovered following
sports-related concussion, however, the increase in S100B was only within a couple hours
following injury and did not persist 2-7 days after (Kiechle et al., 2014). Those findings correlate
with S100B’s suggested short half-life and the thought that extremely high levels are considered
abnormal, but incredibly rare post-injury (Michetti et al., 2012; Morochovic et al., 2009). Our
conclusion is that serum S100B is not a good measure for sports-related concussion at the post
return-to-play time-point suggesting that it may be better suited for immediately following injury
as previous research has found elevated levels at this time-point. More research is needed to
further assess the relationship between concussion and serum S100B levels with a larger sample
and at multiple time points to support this claim.
UCH-L1. Similar to S100B we did not find a significant difference between groups for
UCH-L1, however, we observed a trend (p = .16) where concussion had reduced levels of serum
UCH-L1 relative to the control. Even though we did not find a significant difference, we did
expect to find lower levels of UCH-L1 in the concussed participants. A recent study conducted
following sports-related concussion discovered a decrease of UCH-L1 directly after injury in
comparison to baseline, but did not assess levels past 24 hours post-injury (Welch et al., 2018).
Serum UCH-L1 has also been found to be increased within four hours following nonsports related concussion compared to uninjured controls as well as non-head injury trauma
patients (Papa et al., 2012). Additional research reported overall UCH-L1 increases immediately
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following mild to severe TBI, however, this study did not assess alternative time-points other
than immediately post-injury (Diaz-Arrastia et al., 2014; Li et al., 2015). Other research found
there to be no significant difference in UCH-L1 levels between concussion and control within 24
hours of injury (Kou et al., 2013). Overall, the research is mixed regarding UCH-L1 as a possible
biomarker for concussion, particularly due to the broad scope of previous findings pertaining to
TBI, not specified to mTBI or concussion. Future research should focus on UCH-L1 with a
larger sample at multiple time points following sports-related concussion rather than just
immediately following injury to indicate what role it may play post-injury.
Tau. Although we did not find a significant effect of group on Tau our findings
approached significance (p = .07), where levels of Tau were lower in concussion than control.
This was surprising as we expected to find elevated levels of Tau in concussion relative to
control. One study found an increase in plasma Tau following concussion immediately postinjury when compared to athletes’ own preseason measures (Shahim et al., 2018).
Specifically, Shahim and colleagues (2018) discovered Tau increased within one hour of
injury, decreased at 12 hours following injury, however, levels increased again at 7 days postinjury. Unfortunately, they did not indicate which form of Tau (A-Tau, C-Tau, or T-Tau) they
had assessed making it difficult to distinguish the validity of their timeline (Shahim et al., 2018).
Animal research has evaluated levels of C-Tau in the hippocampus following mTBI, but did not
find differences between mTBI and control groups (Gabbita et al., 2005). Admittedly, our trend
of decreased Tau post-concussion contradicts previous research. However, this trend level effect
calls for more additional blood-based biomarker research at the serum level following sportsrelated concussion post return-to-play.

68

A significant positive correlation was discovered in our findings with Tau and days since
injury. Tau was higher the more time had elapsed since day of injury, in other words as the
number of days since injury increased, Tau increased too (see Figure 2). A recent study
measuring plasma Tau after sports-related concussion evaluated levels with return-to-play, but
not days since injury. No significant difference was found between length of return-to-play and
Tau in their study (Shahim et al., 2018).To our knowledge, we are the first study to report a
relationship between Tau assessed at a return-to-play time point and days since injury following
sports-related concussion.
Summary of findings
Our primary finding was elevated serum-based BDNF post-concussion in recently
cleared to return-to-play collegiate athletes relative to age, sex, and sport-matched controls. This
is an important finding that implicates BDNF’s significant role in neuronal recovery following
concussion. Additionally, our study demonstrated that salivary BDNF is not an adequate measure
of BDNF, although there was a significant correlation between saliva and days since return-toplay. We also found no differences in S100B at the return-to-play time-point in comparison to
controls. Both UCH-L1 and Tau were not significant, but trended towards reduced levels in
concussion relative to control. Despite not being significant, to our knowledge we are the first
study to find lower Tau in concussion at the return-to-play time-point. To the best of our
knowledge, this is also the first evidence for a positive correlation between Tau and days since
injury.
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Hypothesis two: There would be differences in FC and GMV between concussed and
control groups in the following areas: brainstem, prefrontal cortex, and hippocampus.
Group differences were observed at an uncorrected (p = .001) peak level in GMV and
FC, but not at an FDR adjusted (p < .05) cluster level. GMV differences were observed in the
superior frontal gyrus, superior temporal gyrus, post central gyrus and calcarine fissure and
surrounding cortex, where concussion exhibited greater GMV relative to control. Weaker GMV
was also observed in concussion compared to control in the lingual gyrus, calcarine fissure and
surrounding cortex.
Stronger FC was observed in the concussion group between the hippocampus and the
middle and inferior temporal gyrus. Weaker FC was observed in the concussion group between
the hippocampus and the post central gyrus. Stronger FC was observed between the brainstem
and the insula, middle frontal gyrus, middle cingulate and paracingulate gyrus in the concussion
group. Stronger FC was observed between the salience RPFC and the brainstem, SMA, and
cerebellum in the concussion group. Weaker FC was observed in the concussion group between
the salience RPFC and the gyrus rectus, cerebellum, inferior, middle, and superior frontal gyri.
Stronger FC was observed between the frontoparietal LPFC and the superior temporal gyrus,
lingual gyrus, precuneus, cerebellum, calcarine fissure and surrounding cortex in the concussion
group. Weaker FC was observed between the frontoparietal LPFC and the angular gyrus, middle
and inferior frontal gyrus in the concussion group. GMV and FC displayed significant group
differences at an uncorrected peak level, but not an adjusted cluster level.
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Interpretation of findings
Gray Matter Volume. Our findings of significant group differences in GMV following
concussion post return-to-play with age, sex, and sport-matched controls adds to the growing
body of literature outlining the effects of mTBI on the brain. Unlike previous studies that have
found lower GMV in the frontal cortex and temporal lobe, we found significantly higher levels
of GMV in the superior frontal gyrus, post central gyrus, and superior temporal gyrus between
our groups (Churchill et al., 2017; da Costa et al., 2016; Dean et al., 2015). Churchill and
colleagues (2017) discovered athletes with previous concussion history displayed lower volumes
in the frontal cortex, middle temporal lobes, and cerebellum (Churchill et al., 2017). Dean et al
(2015), saw a reduction in middle temporal lobes in their concussed participants compared to
non-injured controls. Da Costa and colleagues (2016) as well as Sussman et al. (2017) also found
decreased GMV in their study participants between injured and control groups, however, neither
study went into detail on where this decrease was specifically located in the brain.
Interestingly, in our study concussion displayed higher and lower GMV in the calcarine
fissure and surrounding cortex, an area of the brain that is vital to visual processing. The
concussion group exhibited lower volume in the lingual gyrus, another area of the brain
pertaining to vision. Even though we found higher and lower GMV differences between groups,
we did not find any differences in the hippocampus, an area of the brain that has been studied
extensively in concussion (Brezova et al., 2014; Terpstra et al., 2017).
Higher GMV in the superior frontal gyrus, postcentral gyrus, superior temporal gyrus,
calcarine fissure & surrounding cortex may be linked to symptoms. These areas in the brain are
important in a number of cognitive variables i.e. working memory, touch, sensations, auditory
processing, and the vison. Whereas lower GMV discovered in the lingual gyrus, calcarine
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fissure, and surrounding cortex are both areas primarily involved with vision. Our findings
suggest these cognitive functions may be connected to possible symptomology following
concussion and the differences in GMV could reflect these. Since all of our concussed athletes
were previously cleared to return-to-play this could also be a potential factor in the differences
we have discovered. That is, it could be possible that these differences in GMV exhibit that the
brain is still healing similar to what our protein levels indicate. Future studies are needed to
assess GMV differences between concussion and control with MRI at a symptom level,
particularly vision i.e. eye tracking and qualitative measures such as visual motor speed via
ImPACT. The role of vision in concussion is extremely important as many sports evolve around
hand eye coordination.
Functional Connectivity. Consistent with previous research, we found significant
differences in FC between concussion and control groups (Bharath et al., 2015; Czerniak et al.,
2015; Dettwiler et al., 2014; Eierud et al., 2014; Meier et al., 2017; Militana et al., 2016; Shin et
al., 2017; Slobounov et al., 2011; Zhu et al., 2015). Our findings indicate there are underlying
functional differences between concussion and control even after concussed athletes have been
medically cleared to return-to-play. Similar to previous research we also found stronger
connectivity in recently concussed athletes relative to controls in the following brain regions:
middle frontal gyrus, SMA, lingual gyrus, superior, middle, and inferior temporal gyri (Czerniak
et al., 2015; Meier et al., 2017). Czerniak and colleagues (2015) also discovered high
connectivity in the inferior frontal gyrus, precentral gyrus, the superior parietal lobule, and the
paracentral gyrus. Meier et al. (2017) also found stronger connectivity in the postcentral gyrus,
paracentral lobule, and fusiform gyrus. Although we did not find any group differences in those
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additional regions we did find stronger connectivity in the insula, middle cingulate and
paracingulate gyrus, brainstem, cerebellum, precuneus, calcarine fissure and surrounding cortex.
Unlike recent research, we discovered lower connectivity in the postcentral gyrus and the
inferior frontal gyrus. In addition, we also discovered lower connectivity in concussion compared
to control in the superior and middle frontal gyri, inferior temporal gyrus, gyrus rectus, angular
gyrus, and cerebellum. Eierud et al. (2014) suggested an anterior-posterior approach when
referring to fMRI results of numerous studies evaluating mTBI following injury. This approach
is based on patterns of reduced connectivity in the anterior portion of the brain and increased
connectivity in posterior areas of the brain (Eierud et al., 2014). Although our results do not
mimic this view entirely, we do have some similarities in respect to anterior regions being
reduced and posterior regions having increased connectivity. These differences with previous
studies could be due to the seed-based regions we used in analysis which were the bilateral
hippocampus, brainstem, salience RPFC, and frontoparietal LPFC. Czerniak et al. (2015), used a
similar analysis plan as ours with the anterior cingulate cortex and bilateral dorsolateral
prefrontal cortex as their seed regions. Slobounov and colleagues (2011) also analyzed their
results in CONN like we did using the primary visual cortex, hippocampus, dorsolateral
prefrontal cortex, and precuneus as ROI-based seeds.
Related to the GMV findings these differences in FC between groups could be lingering
post-concussive abnormalities. It is likely that these differences exist due to the location of
impact when the injury was experienced which then led to a duration of symptoms. However, we
did not collect data on location, but this should be assessed in the future to determine if and how
the area of injury and symptoms endured are linked. Another factor could be the length of injury
as the number of symptomatic days and/or symptom severity could be correlated with
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connectivity. Considering our findings relate to executive function, movement, coordination, and
vision i.e. areas of the prefrontal cortex, cerebellum, temporal gyri these could be possible
explanations for the changes in connectivity between concussion and control. The present study
would need to address some of these factors to determine if they do result in connectivity
differences. Moreover, future studies should acknowledge these possibilities and collect these
data points from their athletes to better determine where these differences are stemming from in
sports-related concussion.
Summary of findings
Gray Matter Volume. Of primary significance is our finding of higher GMV in
concussion relative to control in the superior frontal gyrus, postcentral gyrus, superior temporal
gyrus, calcarine fissure and surrounding cortex. Furthermore, our finding of lower GMV in the
lingual gyrus, calcarine fissure and surrounding cortex in concussion compared to control. These
GMV changes could possibly be reflective of the symptoms an individual (or group) experienced
following injury indicating that the brain has not finished healing despite having been cleared to
return-to-play.
Functional Connectivity. Of primary significance is our finding of additional higher
connectivity regions in the brain following sports-related concussion whereas between groups
concussion was higher relative to control in the insula, middle cingulate and paracingulate gyrus,
brainstem, cerebellum, precuneus, calcarine fissure and surrounding cortex. Moreover, the
discovery of lower connectivity in concussion compared to control in the superior, middle, and
inferior frontal gyri, postcentral gyrus, inferior temporal gyrus, gyrus rectus, angular gyrus, and
cerebellum. These FC differences could be the result of injury location, length of injury, or
symptom severity illustrating underlying lingering post-concussive abnormalities.
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Hypothesis three: Alterations in protein levels would be linked to differences in FC and/or
GMV between groups in the same areas as above.
Differential relationships at an FDR adjusted (p < .05) cluster level were observed
between groups in S100B and GMV as well as UCH-L1 and GMV (see Table 5). Additional
differential relationships were observed between groups in all proteins at an uncorrected (p =
.001) peak level in GMV (see Appendix Tables 6-9). Differential relationships in FC were
observed in serum-based BDNF, S100B, and Tau protein between groups at an FDR adjusted (p
< .05) cluster level (see Table 10). Additional observations of differential relationships at an
uncorrected (p = .001) peak level were made for all proteins between group and FC (see
Appendix Tables 11-14).
Interpretation of findings
Gray Matter Volume. Significant differential relationships between groups in proteins
and GMV were observed in S100B and UCH-L1. Group moderated the relationship between
S100B and GMV, where the association was more positive in the insula in concussion compared
to control. Additionally, differential relationships existed between S100B and GMV in the SMA,
paracentral lobule, postcentral gyrus, superior parietal gyrus, and cerebellum where the
association was more negative in concussion compared to control. Group also moderated the
relationship between UCH-L1 and GMV in the brainstem, where the association was more
positive in concussion compared to control. There were no differential relationships between
groups and GMV with BDNF or Tau. These are novel findings on the effects of sports-related
concussion at the post return-to-play time-point. MRI has been analyzed with Glial Fibrillary
Acidic Protein (GFAP) following mild-severe TBI in the civilian population to assess negative
and positive findings in MRI scans (McMahon et al., 2015; Yue et al., 2019). As far we can tell
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we are the first study to assess and find significance with serum-based biomarkers in conjunction
with GMV following TBI, in particular sports-related concussion.
S100B is known for its role as a screening mechanism for abnormal head CT and
elevated levels are thought to exhibit toxicity indicating cell damage (Bazarian et al., 2013;
Michetti et al., 2012; Unden & Romner, 2010). We did not find a significant main effect of
group in S100B, rather concussion and control had nearly identical levels. Based on the similar
levels of S100B between groups it would seem the brain has entirely healed. However,
differential associations between S100B and GMV were discovered in the insula, SMA,
postcentral gyrus, paracentral lobule, superior parietal gyrus, and cerebellum. All things
considered, S100B may give signs of recovery at a surface level, but biologically demonstrates a
need for further healing hence the associations between S100B and GMV.
UCH-L1 is released as a result of cell destruction and has been measured in direct
proportion to injury severity (Mondello et al., 2014). Like S100B, we did not find a significant
difference between UCH-L1 levels and group, although concussion trended lower than control.
Only one positive association was discovered between UCH-L1 and GMV in the brainstem
which is an area involved with several body functions including wakefulness, breathing, and
heartrate. This association between UCH-L1 and the brainstem may be related to recovery
meaning the brain could be overcompensating for those functions as an outcome of injury.
Ultimately portraying that the brain is still healing.
Functional Connectivity. Group moderated findings of differential relationships
between proteins and FC in BDNF, S100B, and Tau at post return-to-play of recently concussed
collegiate athletes and age, sex, sport-matched controls. These findings add to the recent research
evaluating the possible roles of blood-biomarkers and functional connectivity following TBI.
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Global neural connectivity (GConn) and cerebral blood flow (CBF) has been assessed previously
with BDNF, S100B, and Tau (Di Battista et al., 2018). Negative associations between Gconn and
Tau as well as CBF and Tau existed between healthy controls and acute concussion (1-7 days
following injury) (Di Battista et al., 2018). Athletes with a history of concussion displayed a
differential relationship between decreased Gconn and increased S100B levels, the higher S100B
was the lower their Gconn compared to controls, however, this study did not find any differences
with anything pertaining to BDNF (Di Battista et al., 2018).
Comparable to Thompson and colleagues (2016), we also found differences in FC of the
default mode network, frontoparietal, sensory, auditory, and visual areas of the brain (Thompson
et al., 2016). More specifically we also found negative relationships in FC between S100B and
the default mode network (Thompson et al., 2016). However, we found that group moderated the
relationship between FC and S100B in the middle frontal gyrus and inferior temporal gyrus. We
discovered a similar group difference between FC and BDNF in the middle frontal gyrus and
cerebellum in the salience RPFC where concussion was weaker compared to control. Moreover,
FC in the hippocampus with the medial superior frontal gyrus and superior frontal gyrus was
stronger in concussion relative to control. FC in the frontoparietal LPFC was also stronger with
the cerebellum in concussion compared to control. Like, our GMV findings to the best of our
knowledge we believe we are the first study to analyze and examine serum-based biomarkers and
FC together following sports-related concussion.
As mentioned, S100B may be able to demonstrate further need for healing in the brain
with GMV and is no different with FC. Negative differential associations were observed between
S100B and FC in the middle frontal gyrus and inferior temporal gyrus. These findings point out
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that the brain is likely not using these regions as efficiently as it could be due to concussion and
could be the reason behind difficulties experienced with attention and perception.
BDNF is thought to have a role in active recovery following head injury. We found
significantly elevated levels of serum BDNF in concussion relative to control implying that the
brain is indeed still healing despite subsiding symptoms. Similar to S100B, negative associations
were also observed between BDNF and FC in the middle frontal gyrus and cerebellum. The
cerebellum has been implicated in concussion research as a common symptom is disruption of
balance and coordination (Churchill et al., 2017). However, the cerebellum has recently been
thought to have a role in anxiety (Moreno-Rius, 2018). Interestingly, BDNF has also been
associated with stress-related factors including anxiety and attentional bias to threat (Aydemir et
al., 2005; Carlson et al., 2014). Although we controlled for DASS it is likely due to the
subjectivity of self-report questionnaires that the association we have discovered between the
cerebellum and BDNF could be a result of anxiety, especially when all levels of depression,
anxiety, and stress were significantly elevated in our concussion group compared to control
(Carlson et al., 2020).
Tau is most known for its role in Alzheimer’s, however, it is also a protein that has been
found to display differences following TBI (Barrio et al., 2015). We did not find significance
between groups, but did discover a trend where concussion Tau levels tended to be lower than
controls. Unlike BDNF and S100B, we observed positive associations between Tau and FC in
the superior and medial superior frontal gyrus and the cerebellum. These associations could
potentially indicate the brain overcompensating in these areas due the brain needing more time to
recover. This is plausible given the lower levels of Tau relative to controls, but also could be in
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response to prolonged memory, balance, and/or anxiety symptoms experienced even after being
cleared to return-to-play.
Summary of findings
Gray Matter Volume. Of great significance are our novel findings between groups with
proteins and GMV. Significant differences were found between S100B and GMV as well as
UCH-L1 and GMV at an adjusted (p < .05) clustered level. At an uncorrected (p = .001) peak
level, all proteins and GMV displayed significance. As far as we know we are the first study to
evaluate BDNF, S100B, UCH-L1, Tau, and GMV together at return-to-play post sports-related
concussion.
Functional Connectivity. Of great significance are our novel findings between groups
with proteins and FC in the salience RPFC, hippocampus, and frontoparietal LPFC seed regions.
Group moderated the effect of FC with BDNF, S100B, and Tau at an adjusted (p <.05) cluster
level. Comparable to our GMV results, all proteins and FC exhibited significance at an
uncorrected (p = .001) peak level. To the best of our knowledge, we are the first study to assess
serum-based biomarkers and rsFC together following at return-to-play following sports-related
concussion in comparison with age, sex, and sport-matched controls.
Limitations and Future Directions
The present study has several limitations that need to be considered when drawing
conclusions from our findings and designing future studies. First, we had a small sample size,
future research should replicate our findings at a larger scale. G*Power analyses with our
observed effect sizes determined that a total of 130 participants are needed for UCH-L1 and 72
participants are needed for Tau in order to reach significance based on the present findings.
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Second, there was variability in the time of our sample collection, however, this was matched
across groups so it is unlikely that this affected our results. Nonetheless future studies should be
replicated with stricter timing guidelines for sample collection. Third, our study did not account
for diurnal variation which has been previously related to BDNF and S100B, but not UCH-L1
and Tau (Morera-Fumero et al., 2017; Piccinni et al., 2008). To avoid any diurnal variation
future research may need to base sample collection time on a participant’s sleep-wake cycle
rather than a set time of day. Fourth, we only assessed one return-to-play time point and had a lot
of variability in the time course of recovery following sports-related concussion. Future studies
should develop more than one set time point to better evaluate the effect of concussion on bloodbased biomarkers and to avoid any wide variation during recovery. Fifth, our current Tau data is
the result of a failed standard curve and will need to be reassessed before these results can be
taken with serious consideration. Running ELISAs should take precautions and always remake
the standard curve to avoid any poor outcomes. Sixth, we did not account for the effect of
exercise on these protein levels and have been previously found to have an effect on BDNF,
S100B, UCH-L1, and Tau (Bamac et al., 2011; Dang et al., 2014; Daniele et al., 2018; Liu et al.,
2010; McGeown et al., 2016; Schulte et al., 2014).
Other proteins should potentially be studied to gain a better representation of the effects
of sports-related concussion on blood-based biomarkers. Future studies should consider selecting
proteins based on symptomology to possibly develop a more personalized method of treatment
post-injury. These effects should also be studied long-term ideally to also study the effects of
repetitive head injury and maybe grant insight into chronic traumatic encephalopathy. More
studies should study blood and saliva concurrently to assess the possibility of saliva being a
potential biomarker for concussion.
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Clinical Implications
Due to the complexity and heterogeneity of the brain, the current approach of clinical
examination and neuroimaging to diagnose concussion has being proven inadequate (Mondello
et al., 2014). The use a blood biomarker is minimally invasive compared to neuroimaging,
readily available (i.e. used in a hospital or on a sideline), and cost effective (Kawata et al., 2016).
Various studies have already provided evidence of biomarkers and their ability to successfully
diagnose concussion (Bazarian et al., 2013; Kawata et al., 2018; Kiechle et al., 2014; Kou et al.,
2013; Li et al., 2015; Papa et al., 2012; Randall et al., 2013; Shahim et al., 2018; Susa et al.,
2019; Unden & Romner, 2010). Furthermore, the addition of biomarkers to injury diagnosis does
not fall on one single protein or measure, rather on multiple. Having more than one biomarker
increases the likelihood of diagnosis accuracy as well as provide outcome prediction following
injury. However, a major limitation is the inability to decide which biomarkers should be used
and a complete lack of replication (Kawata et al., 2016; Kim et al., 2018; Mondello et al., 2014;
Zetterberg et al., 2013). A clear set of guidelines illustrating time points and the type of
biomarker i.e. serum, plasma, or saliva would lead to overall better replication and
reproducibility for the development of new methodology in the assessment and treatment of
concussion. With a consensus larger scale studies would ultimately provide the evidence and
validation necessary in making this approach available for patients.
Practical Implications
Our findings of significant differences between BDNF, S100B, UCH-L1, and Tau with
GMV and FC indicate that the brain is still actively recovering despite athletes having recently
been cleared to return-to-play following sports-related concussion. The current approach to clear
athletes and/or individuals from concussion is likely not a result of a healed injury, but rather
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solely due to the absence of symptoms. Better medical practices need to be made surrounding
concussion to reduce mental illness and save lives i.e. in particular the return-to-play protocol
must be modified for athletes of all skill level.
The world of sports as we know it will need to change for concussion safety to take
precedence. Every athlete, coach, and parent need to be educated on the signs and severity of
concussion in order to make sports a safer place. Head injuries are not to be taken lightly and if
someone must sit out an important game or race then this needs to be done. Without proper
education on concussion, coaches, and parents lacking in education may be unknowingly putting
the health and safety of their youth athletes at risk. It is not uncommon for risks to be taken with
"star players" because of a failure to understand the potential damage associated with
concussion. As shown in our research, even though symptoms may have subsided, the brain is
far from fully-healed after athletes have been medically cleared to return-to-play. There is
increased risk of further injury and the development of disorders later in life. While all risk of a
concussion happening in sport cannot be removed, post-concussion care has substantial room for
improvement in order to reduce the risks of serious, and potentially life-changing outcomes.
If we do not keep athletes safe starting at a young age then their safety will not be priority
as they continue to move up to the high school, college, and professional level. Major sports
leagues should be aware that in order for their athletes to play at their highest potential there
needs to be stricter return-to-play regulations. Athletes must be given the proper amount of time
to let their brain heal beyond the absence of symptoms.
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Conclusion
To the best of our knowledge, this is the first study to analyze serum-based protein levels
in conjunction with MRI measures following sports-related concussion. Findings of this study
indicate protein-based biomarkers may have implications for targeting clinical assessment of
sports-related concussion. Serum-based BDNF was the most effective measure to differentiate
between concussion and control following return-to-play. Although S100B, UCH-L1, and Tau
were not significant across groups, differential relationships were observed in GMV and FC of
every protein. This study provides novel findings of the relationships between BDNF, S100B,
UCH-L1, and Tau with whole brain GMV and hippocampus, brainstem, salience RPFC, and
frontoparietal LPFC seed-based FC. Furthermore, these findings suggest that GMV and FC
differences with BDNF, S100B, UCH-L1, and Tau may be linked to a number of factors
including location of impact, duration of injury, symptom type and severity. Protein-based
biomarkers may be useful in measuring the effects of concussion post return-to-play at a
symptom level. Overall, the usage of blood biomarkers in partnership with MRI could lead to
improved diagnosis and treatment of concussion.
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Appendix
Gray Matter Volume Additional Tables
Table 6. GMV BDNF
Concussion > Control
Region
Middle Occipital Gyrus
Cerebellum
Cerebellum
Control > Concussion
Region
Insula Left
Inferior Temporal Gyrus
Inferior Temporal Gyrus
Superior Occipital Gyrus

All differences significant at p < .001 uncorrected

109

Hemisphere

kE
20
89
25

t-value
5.64
4.71
4.29

Coordinates (xyz)
-23, -90, 2
-12, -77, -32
15, -77, -35

Hemisphere
Left
Right
Right
Right

kE
65
24
20
22

t-value
5.88
5.62
4.83
4.66

Coordinates (xyz)
-36, 11, -14
60, -32, -19
42, 3, -45
18, -87, 17

Table 7. GMV S100B
Concussion > Control
Region
Insula
Supramarginal Gyrus
Superior Frontal Gyrus
Superior Frontal Gyrus
Superior Frontal Gyrus
Precentral Gyrus
Supramarginal Gyrus
Insula
Insula
Control > Concussion
Region
Supplementary Motor Area
Supplementary Motor Area
Cuneus
Cerebellum
Supplementary Motor Area
Inferior Frontal Gyrus
Superior Parietal Gyrus
Precuneus
Parahippocampal Gyrus
Paracentral Lobule
Postcentral Gyrus
Superior Frontal Gyrus
Superior Temporal Gyrus
Supramarginal Gyrus
Paracentral Lobule
Superior Frontal Gyrus

Hemisphere
Left
Right
Left
Right
Left
Right
Left
Left
Left

kE
1011
60
29
23
24
21
43
20
31

t-value
7.22
6.06
5.14
4.88
4.31
4.26
4.14
3.99
3.93

Coordinates (xyz)
-32, -8, 14
59, -42, 33
-11, 60, -8
18, 60, 2
-14, 6, 51
36, -11, 56
-56, -35, 23
-30, 18, 2
-27, 20, -9

Hemisphere
Left
Left
Left

kE
124
148
109
804
428
56
366
30
89
386
501
56
23
24
39
23

t-value
6.20
5.90
5.79
5.70
5.46
5.45
5.15
5.13
5.09
4.83
4.77
4.68
4.53
4.41
4.15
4.06

Coordinates (xyz)
0, -8, 66
0, 2, 53
-5, -89, 33
-3, -50, -3
-2, 18, 65
-30, 33, -14
26, -74, 57
6, -50, 57
21, -26, -23
12, -27, 78
-21, -30, 72
0, 50, 15
23, 5, -20
53, -17, 26
-2, -33, 63
5, 47, 50

Left
Left
Right
Right

Left
Left
Right
Right
Left
Right

All differences significant at p < .001 uncorrected
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Table 8. GMV UCH-L1
Concussion > Control
Region
Brainstem
Brainstem
Brainstem
Cerebellum
Superior Frontal Gyrus
Control > Concussion
Region
Precentral Gyrus
Calcarine Fissure and Surrounding Cortex

Hemisphere

Left

kE
417
170
25
25
56

t-value
6.32
4.67
4.29
4.06
4.04

Coordinates (xyz)
-5, -18, -32
3, -32, -59
11, -26, -21
24, -41, -56
-30, -8, 68

Hemisphere
Left
Left

kE
169
33

t-value
4.55
4.34

Coordinates (xyz)
-30, -6, 48
2, -74, 14

All differences significant at p < .001 uncorrected
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Table 9. GMV Tau
Concussion > Control
Region
Rolandic Operculum
Precentral Gyrus
Brainstem
Middle Frontal Gyrus
Inferior Frontal Gyrus
Control > Concussion
Region
Anterior Cingulate & Paracingulate Gyri
Inferior Frontal Gyrus
Fusiform Gyrus
Lenticular Nucleus Putamen
Superior Frontal Gyrus
Superior Temporal Gyrus

Hemisphere

Left
Right

kE
61
41
144
27
20

t-value
5.52
5.12
4.63
4.56
4.51

Coordinates (xyz)
47, -3, 11
-33, -15, 51
3, -33, -59
-41, 36, 27
53, 14, 11

Hemisphere
Right
Right
Left
Right
Left
Left

kE
177
76
63
21
21
24

t-value
5.56
5.19
4.98
4.62
4.33
4.29

Coordinates (xyz)
11, 48, 11
30, 23, -12
-41, -65, -18
26, 12, 3
-18, 27, 45
-50, 3, -9

Left

All differences significant at p < .001 uncorrected
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Functional Connectivity Additional Tables
Table 11. FC BDNF
Concussion > Control
Seed

Region

Hemisphere

kE

t-value

Hippocampus Right
Hippocampus Left

Inferior Temporal Gyrus
Inferior Temporal Gyrus
Superior Frontal Gyrus
Insula
Middle Frontal Gyrus
Middle Frontal Gyrus
Median Cingulate &
Paracingulate Gyri
Cerebellum
Brainstem
Brainstem
Middle Frontal Gyrus
Cerebellum
Brainstem
Superior Temporal Gyrus
Superior Temporal Gyrus
Middle Temporal Gyrus
Cerebellum

Right
Right
Right
Left
Right
Left

25
40
24
75
51
125

4.08
4.74
4.00
5.94
5.07
4.99

Coordinates
(xyz)
58, -8, -36
60, -10, -36
30, 62, 10
-32, 16, -4
30, 24, 34
-34, 36, 34

Right

38

4.32

6, -32, 46

28
66
31
34
61
25
50
47
28
36

4.02
5.18
5.09
4.80
4.79
4.26
5.69
4.58
4.73
4.07

36, -50, -38
0, -38, -34
-6, -38, -52
-22, 22, 34
-28, -78, -34
12, -28, -42
42, -28, -2
-44, 20, -22
-48, 14, -36
40, -80, -28

Seed

Region

Hemisphere

kE

t-value

Hippocampus Right
Hippocampus Left
Salience RPFC Left

Cerebellum
Brainstem
Inferior Temporal Gyrus
Superior Frontal Gyrus
Cerebellum
Gyrus Rectus
Cerebellum
Middle Frontal Gyrus
Inferior Temporal Gyrus
Inferior Temporal Gyrus
Middle Frontal Gyrus
Middle Frontal Gyrus
Caudate Nucleus
Inferior Frontal Gyrus
Middle Occipital Gyrus
Inferior Frontal Gyrus

25
91
143
66
22
40
71
109
32
22
40
26
68
56
66
25

4.89
5.04
5.95
5.04
4.80
4.51
4.35
4.22
4.19
4.32
4.01
5.13
5.02
4.81
4.25
4.87

Brainstem

Salience RPFC Left
Salience RPFC Right

Frontoparietal LPFC Left
Frontoparietal LPFC Right

Left

Right
Left
Left

Control > Concussion

Salience RPFC Right
Frontoparietal LPFC Left

Frontoparietal LPFC Right

All differences significant at p < .001 uncorrected
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Right
Right
Right
Right
Left
Left
Right
Right
Left
Left
Left
Right

Coordinates
(xyz)
-24, -30, -36
-6, -22, -46
68, -26, -28
18, -12, 66
-46, -64, -50
8, 32, -22
42, -64, -44
42, 52, -6
-48, -36, -28
-44, -30, -26
48, 46, 4
46, 14, 54
-6, 8, 8
-18, 28, -20
-32, -62, 34
22, 24, -20

Table 12. FC S100B
Concussion > Control
Seed

Region

Hemisphere

kE

t-value

Hippocampus Left

Inferior Temporal Gyrus
Superior Frontal Gyrus
Lingual Gyrus
Insula
Middle Frontal Gyrus
Middle Frontal Gyrus
Supramarginal & Angular Gyri
Middle Frontal Gyrus
Brainstem
Brainstem
Cerebellum
Inferior Temporal Gyrus
Superior Temporal Gyrus
Cerebellum
Cerebellum
Paracentral Lobule
Superior Temporal Gyrus
Superior Temporal Gyrus
Precuneus
Precuneus
Lingual Gyrus
Calcarine Fissure &
Surrounding Cortex

Right
Left
Left
Left
Left
Right
Left
Right

Left
Right
Left
Left
Right
Right

44
39
33
96
189
50
24
21
46
33
29
22
27
31
44
72
45
31
47
22
55

4.98
4.41
4.12
6.69
5.28
5.02
3.96
3.94
5.27
4.76
4.55
4.47
5.22
4.79
4.55
5.50
4.88
4.70
4.13
4.10
3.92

Coordinates
(xyz)
60, -10, -36
-10, 62, 20
-20, -92, -20
-32, 16, -4
-34, 36, 34
32, 26, 36
-44, -42, 42
30, 46, 20
-6, -38, -52
0, -36, -36
12, -44, -16
-36, 4, -40
-22, 20, 32
16, -42, -18
-24, -70, -36
-8, -26, 56
48, -8, -8
-44, 22, -24
-6, -48, 56
8, -46, 58
10, -80, -12

Left

23

3.74

2, -88, 12

Seed

Region

Hemisphere

kE

t-value

Hippocampus Right

Cerebellum
Inferior Frontal Gyrus
Inferior Temporal Gyrus
Superior Frontal Gyrus
Cerebellum
Inferior Temporal Gyrus
Middle Frontal Gyrus
Cerebellum
Inferior Frontal Gyrus
Middle Frontal Gyrus
Angular Gyrus
Inferior Frontal Gyrus
Olfactory Cortex
Middle Occipital Gyrus
Inferior Frontal Gyrus
Middle Frontal Gyrus

79
20
180
101
26
48
181
80
150
46
76
23
49
22
40
30

5.22
3.94
8.06
5.62
5.33
4.97
4.79
4.40
5.89
5.11
4.53
4.41
4.39
4.06
5.01
3.93

Brainstem

Salience RPFC Left

Salience RPFC Right

Frontoparietal LPFC Left

Left
Left

Control > Concussion

Salience RPFC Left

Frontoparietal LPFC Left

Frontoparietal LPFC Right

All differences significant at p < .001 uncorrected
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Right
Right
Right

Right
Left
Right
Right
Right
Left
Left
Right
Left

Coordinates
(xyz)
-24, -30, -36
34, 6, 30
64, -26, -28
20, -12, 66
-46, -64, -50
-54, -42, -26
38, 60, -6
46, -62, -42
-18, 28, -20
46, 16, 54
58, -54, 34
52, 40, -16
6, 14, -10
-34, -64, 36
20, 22, -22
-40, 44, 28

Table 13. FC UCH-L1
Concussion > Control
Seed

Region

Hippocampus Right

Corpus Callosum
Postcentral Gyrus
Superior Frontal Gyrus
Corpus Callosum
Lingual Gyrus
Lingual Gyrus
Middle Frontal Gyrus
Superior Frontal Gyrus
Cerebellum
Precuneus
Cerebellum
Superior Frontal Gyrus
Precuneus
Inferior Frontal Gyrus
Cerebellum
Superior Frontal Gyrus
Superior Temporal Gyrus
Insula
Calcarine Fissure &
Surrounding Cortex
Cerebellum
Cerebellum
Cerebellum

Hippocampus Left

Brainstem
Salience RPFC Left
Frontoparietal LPFC Left

Frontoparietal LPFC Right

kE

t-value

Left
Right
Right

37
34
68
29
25
35
123
90
45
27
46
134
37
20
36
45
28
38

5.65
5.50
4.98
4.62
4.32
4.28
5.22
4.81
4.46
4.40
4.36
4.15
3.90
4.34
5.59
5.06
5.16
4.32

Coordinates
(xyz)
10, -34, 20
66, 2, 16
-10, 22, 56
-8, -36, 18
-2, -62, 2
-28, -90, -20
24, 28, 40
-18, 32, 46
-4, -60, -16
8, -44, 16
-14, -60, -40
6, 56, 6
-4, -54, 34
-40, 28, -8
18, -78, -44
-14, 2, 76
48, -6, -8
44, 20, -10

Left

27

4.18

0, -94, -4

39
184
22

3.82
4.85
4.15

0, -82, -16
42, -80, -30
-4, -82, -22

Hemisphere
Right
Left
Left
Left
Right
Left
Right
Right
Left
Left

Control > Concussion
Seed

Region

Hemisphere

kE

t-value

Salience RPFC Left

Lingual Gyrus
Median Cingulate &
Paracingulate Gyri
Inferior Occipital Gyrus
Middle Occipital Gyrus
Middle Frontal Gyrus
Inferior Temporal Gyrus

Left

22

4.49

Coordinates
(xyz)
-20, -80, -4

Left

65

4.21

0, -26, 36

Right
Right
Right
Left

32
21
27
38

4.13
3.84
4.28
4.18

36, -82, -16
32, -86, 4
50, 18, 50
-52, -6, -28

Frontoparietal LPFC Left

All differences significant at p < .001 uncorrected
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Table 14. FC Tau
Concussion > Control
Seed
Hippocampus Right

Hippocampus Left

Brainstem

Salience RPFC Right
Frontoparietal LPFC Left
Frontoparietal LPFC Right
Control > Concussion
Seed
Hippocampus Right

Salience RPFC Left

Region
Superior Frontal Gyrus
Corpus Callosum
Superior Frontal Gyrus
Lingual Gyrus
Superior Frontal Gyrus
Middle Frontal Gyrus
Superior Frontal Gyrus
Superior Frontal Gyrus
Lingual Gyrus
Median Cingulate &
Paracingulate Gyri
Superior Frontal Gyrus
Cerebellum
Middle Frontal Gyrus
Inferior Temporal Gyrus
Inferior Frontal Gyrus
Middle Frontal Gyrus
Cerebellum

Hemisphere
Left

Region
Cerebellum
Cerebellum
Superior Temporal Gyrus
Cerebellum
Cerebellum
Superior Frontal Gyrus
Inferior Temporal Gyrus
Median Cingulate &
Paracingulate Gyri
Angular Gyrus
Middle Frontal Gyrus

Hemisphere

All differences significant at p < .001 uncorrected
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Left
Left
Left
Right
Left
Left
Left

kE
149
23
235
24
22
142
186
109
57

t-value
5.14
4.90
4.80
4.39
3.92
5.65
4.92
4.78
4.74

Right

67

4.52

4, -30, 46

Right

28
21
28
23
26
21
189

4.50
4.25
4.07
4.01
4.12
4.44
4.94

22, 44, 38
26, -60, -58
32, 26, 38
54, -54, -12
36, 18, -22
-30, 32, 52
34, -78, -28

Right
Right

kE
25
52
20
21
42
30
22

t-value
5.03
5.03
4.63
4.44
5.46
5.13
4.22

Left

56

4.18

0, -26, 40

Right
Right

21
31

3.93
3.91

36, -64, 50
42, 52, -6

Right
Right
Right
Left

Right

Coordinates (xyz)
-16, 26, 52
-8, -36, 16
-6, 66, 2
-2, -62, 4
-16, 58, 14
26, 28, 32
-2, 54, 6
-18, 36, 46
-22, -90, -18

Coordinates (xyz)
-24, -30, -38
24, -30, -42
50, -24, 4
-42, -40, -30
-46, -64, -50
18, -12, 66
68, -26, -28

MEMORANDUM
TO:

Joshua Carlson
Department of Psychological Science
Maggy Moore
School of Health and Human Performance
Taylor Susa
Department of Psychological Science

DATE:
FROM:

September 4, 2019
Lisa Schade Eckert, Ph.D.
Dean of Graduate Education and Research

RE:
Modification to HS15-680
Original IRB Approval Date: 8/19/2015
Expiration Date: 9/3/2020
Modification Approval Date: 9/4/2019
“Optical Imaging the Neural Correlates Post- Concussion”

Your modification for the project “Optical Imaging the Neural Correlates Post- Concussion” has been
approved by the Northern Michigan University Institutional Review Board. Please include your proposal
number (HS15-680) on all research materials and on any correspondence regarding this project.
Any additional personnel changes or revisions to your approved research plan must be approved by
the IRB prior to implementation. Unless specified otherwise, all previous requirements included in your
original approval notice remain in effect.

If you have any questions, please contact the IRB at hsrr@nmu.edu.
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